Office of the PresidentOffice of the Provost & Academic AffairsAccounting and FinanceDevelopmentHuman ResourcesInformation Technology ServicesLibrary & Learning ResourcesMarketing and CommunicationsOperationsRegistrarTeaching and Learning
Florence T. Dunn
President
With more than three decades of banking experience in California’s Central Valley, Florence Dunn has an extensive record of helping organizations of all kinds succeed in that region’s unique economy. Prior to joining the University, Mrs. Dunn was Senior Vice President and Regional Manager for the Sacramento and Central Valley regions of California Bank & Trust. In that position she played a leadership role in the bank’s strategic planning, and she oversaw marketing for two geographically vast and rapidly growing regions within the state.
She has advised hundreds of organizations, ranging from agriculture and manufacturing to education and health care. Mrs. Dunn is a long-time advocate for professional education and community service. She currently serves on the 23rd Assembly District Health Advisory Committee and the Board for the Fresno Economic Development Corporation. She previously served for eleven years on the Board for Community Hospitals of Central California and is the Immediate Past Chair, in addition to the Better Business Bureau of the San Joaquin Valley.
Senior Vice President for Academic Affairs and Provost Dean, College of Pharmacy 559-325-3600 wduncan@chsu.edu
Biography
Wendy Duncan, PhD, is a distinguished expert in new program evaluation and development and curriculum design and assessment. With extensive experience in strategic planning and change management, she is a visionary with a passion for developing innovative learning and scholarly opportunities for students. Prior to joining CHSU, Dr. Duncan served as Dean in the College of Pharmacy and Health Sciences and Professor at Drake University in Des Moines, Iowa and as Vice President of Academic Affairs, Dean of Pharmacy, and Professor at St. Louis College of Pharmacy. Prior to her appointment as Dean, she served as a faculty member at the University of Toronto and as Associate Dean for Education and Director of the Office of Teaching, Learning and Assessment at Auburn University’s Harrison School of Pharmacy. Duncan received her Bachelor of Science in Pharmacy and PhD in Pharmaceutics from the University of Toronto.
At both St. Louis College of Pharmacy and Auburn University Harrison School of Pharmacy, Duncan instituted curricular transformation with the extensive use of team-based and problem-based learning and a greater focus on practice management, advocacy and community service. Duncan has demonstrated her comprehensive understanding of accreditation procedures through the successful completion of self-studies resulting in accreditation and reaccreditation at four institutions at both the programmatic and regional level and by serving as a site evaluator for the American Council for Pharmaceutical Education since 2007. Duncan also conveys a strong focus on intra- and inter-professional coalitions and research and she formally instituted the Des Moines Area Interprofessional Collaborative among five colleges and universities. She was instrumental in amassing the Missouri Pharmacy Coalition, a consortium of colleges, state pharmacy organizations and board members creating a legislation- and policy-focused alliance. She was responsible for developing inter-professional alliances with Saint Louis University, Washington University School of Medicine, and Goldfarb School of Nursing providing new educational, practice, and research opportunities for students and faculty.
Collaborating with the academic affairs office and the provost’s council, Wendy ensures the academic integrity of the university and supports innovations in programs and methods of delivery which respond to the changing demands of the future workforce in the health sciences.
Director of Institutional Assessment, Effectiveness and Research 559-472-0873 swragg@chsu.edu
Biography
Stephanie provides leadership and performs functions related to the collection, interpretation, and use of institutional data for planning, research into effectiveness and decision making. She works closely with the assessment leadership of the CHSU colleges.
Office of Institutional Assessment, Effectiveness and Research (OIAER) webpage
Patty Havard, PharmD
Associate Dean for Interprofessional Community Engagement and Professor 559-797-9016 phavard@chsu.edu
Biography
Patty designs, facilitates and improves rich community-engaged, interprofessional, co-curricular experiences that focus on interprofessional education, and community and civic engagement. The experiences will enable CHSU to achieve national prominence in the design and implementation of co-curricular experiences that bind us to the community and advance our mission.
Come to me for ...
•
Suggesting new partnerships and projects that have the potential of engaging a significant number of students
•
Volunteering for existing programs and activities
•
Volunteering for leadership within current or new engagement activities
With McKenna’s eye steadily on student success, a collaborative and trusting university culture, excellence, and efficiency, and serving as an advocate and coordinator for staff and academic affairs, she helps us all get things done right. As the lead in PEARL, she is our expedition leader into understanding how effectively and reproducibly to develop students’ affective domain.
Come to me for ...
•
Academic Affairs policies and procedures (including exams, attendance)
•
BPPE compliance
•
Formal academic complaints and concerns
•
Staff development ideas or workload concerns
•
Academic budget management and monitoring
•
Coordinating academic affairs functions across the university
•
Managing the BOT Academic Affairs Committee meeting agendas and documents
•
Student success program oversight including PEARL, Learning Specialists, and the TA and Tutoring programs
With over thirty years of executive financial management experience working for firms including Ernst & Young, KB Home, Vallicorp Holdings and Assemi Group, Inc., Derek W. Hayashi, CPA serves as our Chief Financial Officer. In his role with CHSU, Mr. Hayashi is responsible for the management of all financial affairs of the University. He oversees the Office of Operations Administration, which includes Facility, Information Technology and Human Resources. Also, he is responsible for the development of the University’s long term strategic financial plan.
Mr. Hayashi earned his Bachelor of Science degree in accounting and finance from the Walter Haas School of Business at UC Berkeley in 1986 and became a Certified Public Accountant in 1990. He has been active in many professional organizations including the American Institute of Certified Public Accountants, California Society of Certified Public Accountants and professional business fraternity Delta Sigma Pi. He also is a Board Member of the Fresno Economic Development Corporation and an Advisory Committee Member of the California Drought Coalition.
Anna’s role is to ensure that the library has access to resources in support of the curriculum, research, and life-long learning needs of those at CHSU. She manages all aspect of the library; personalized customer service, collection development, budgeting, creation of library policies and procedures, negotiating contracts for resources, research assistance, and more. Her true passion lies in connecting people with information that is both efficient and useful.
Come to me for ...
•
All library resources – both physical and digital
•
Collection development
•
Textbooks and resources for courses
•
Research assistance
•
Copyright Compliance
•
Library standards – ACRL, ACPE, COCA
•
Gamification – building a learning experience using game elements
Richele Kleiser
Vice President, Marketing and Communications 559-272-8192 rkleiser@chsu.edu
Richele Kleiser has over 20 years of experience with leadership roles in Marketing, Communications, Public Relations, Fundraising and Customer Service within Higher Education, Home Building, Retail and Non-Profit sectors. Prior to joining CHSU, Ms. Kleiser directed the Marketing, Customer Service and Granville Home of Hope functions at Granville Homes, one of Fresno’s largest and most prestigious home builders and developers. With 18 years of service at Gottschalks, Inc. - the largest regional department store of its time on the west coast - she was responsible for the Advertising/Marketing, Private Label Credit Card and Customer Service divisions.
Ms. Kleiser is a highly-motivated, results driven professional with strong decision-making and strategic planning skills. While creating new programs, exploring new directions and moving her institution forward, she works diligently to build strong, lasting relationships with her constituents and partners, as well as with her internal team and colleagues.
Assistant Vice President for Operations 559-325-3600 jdunn@chsu.edu
James “Jimmy” Dunn has over ten years of retail experience working as a General Manager for a large national retail chain then moving to the California Central Coast to establish a de novo independent retail pharmacy, and was responsible for HR, IT and facilities management. Jimmy was also responsible for establishing relationships with healthcare providers and skilled nursing facilities and building a client base from the ground up. Jimmy completed his undergraduate degree in psychology with a minor in communications from Cal State University San Jose in 2005. He is a licensed pharmacy technician, a credentialed Facilities Management Professional and currently provides administrative leadership and operational oversight for CHSU’s Facilities Management, Human Resources, Information Technology and all Facility Expansion Projects. As a member of the Universities senior management team, Jimmy works with all departments to integrate educational, fiscal, technological, facilities and personnel planning to achieve the University’s mission and vision.
Jimmy currently serves on the Board of Directors for Clovis Chamber of Commerce, Immediate Past Chair; Foundation Board of Directors Clovis Unified School District, Endowment Committee; Board of Directors for the Better Business Bureau serving the Central California & Inland Empire Counties; and Leadership Fresno Steering Committee, Ad Hoc Member. He is an alum of Leadership Fresno – Class 30 and was a Founding Father of Delta PI chapter of PI Kappa Alpha at San Jose State where he served as Vice President and Recruitment Chair.
Jonathan ensures the accuracy, security, maintenance, and integrity of all student records and data. He develops, reviews, and approves policies and procedures to ensure the University is compliant with all accrediting bodies. Jonathan administers annual FERPA training to all staff, faculty, and students. He is also responsible for applying and upholding the policies that are found in the academic catalog and student handbook.
Come to me for ...
•
Student record management
•
Academic calendar and course schedules
•
Transcripts
•
Final student grades and grade changes
•
Team assignments for students
•
Brightspace course setup
•
FERPA
•
Alternative progression plans (APP)
•
Graduation requirements
•
Professional & licensing suppor
•
Curricular compliance
•
Student Handbook/Catalog
Will Ofstad, PharmD, BCPS, CDE
Assistant Dean for Education Director, Office of Teaching and Learning 559-374-2230 wofstad@chsu.edu
Biography
Department: • Clinical Sciences
Year Began at CHSU: • 2015
Current Classes Taught: • PHR 645 Patient Care II
Education: • Kaiser Permanente, Diablo Service Area, Walnut Creek, California, Pharmacy Practice Residency
• University of California, San Francisco (UCSF), San Francisco, California, Doctor of Pharmacy
• California Institute of Technology (Caltech), Pasadena, California, Bachelor of Science, Chemical Engineering
• Whitman College, Walla Walla, Washington, Bachelor of Arts, Chemistry
Professional Affiliations: • American Association of College of Pharmacy • Northern California College of Clinical Pharmacy • American College of Clinical Pharmacy • Team-Based Learning Collaborative • California Simulation Alliance
Professional Service: • Team-Based Learning Collaborative (TBLC), Consultant-Trainer Program, Co-facilitator • 15th Annual TBLC Meeting, Program Committee • California Interprofessional Education Research Academy, Cofounder • American College of Clinical Pharmacy (ACCP), Past-President Northern California Chapter • UC Davis Medical Center
Experience: • Certified Diabetes Educator (CDE) • TBL Consultant Trainer, certified by the Team-Based Learning Collaborative • APhA Pharmacist & Patient-Centered Diabetes Care • Board Certified Pharmacotherapy Specialist • Trainer of Immunization Administration certified by Drug Store News • Cardiopulmonary resuscitation (CPR) certified by the American Heart Association • Emergency Contraception certified by Pharmacy Access Partnership • Pharmacy-Based Immunization Delivery certified by ASHP • California Registered Pharmacist, License No. RPH 61775
Awards: • Ken Miller Award for Assessment of Educational Effectiveness, 2015 • Jeff King Pharmacy Leadership Award, Nominee, 2014 • Peer Award in Teaching, 2013 • Teacher of the Year, 2013 • Teacher of the Year, 2012 • Outstanding Community Service Award, 2011 • Grant Recognition Award, 2011 • Bowl of Hygeia Award, Nominee, 2008 • UC Regents Scholar, 2006-2008 • The Long Award for Excellence in Teaching, 2007 • The Long Award for Excellence in Teaching, 2006 • UCSF Dean’s Apple Teaching Award, 2006 • UCSF Dean’s Apple Teaching Award, 2005 • UCSF Frank M. Goyan Award, 2005
Latest Projects & Publications:
Integration of IPE into the Curriculum: ACPE Standard 11
The Evidence Behind High Performing Teams
Pathways to Expand the Effectiveness of Teaching and Learning: A workshop for educators to engage active learning strategies and explore team-based learning (TBL)
Exploring Team Contracts to Build Better Teams
Optimizing Team Building in TBL: Days 1 through 100
A Comparison between a Simulation-Based and Traditional Direct Patient Care Introductory Pharmacy Practice Experiences
A Bridge to Quality: The Pharmacist-Managed Primary Care Clinic
Development of a Team Contact for Team-Based Learning
The Impact of Grading Readiness in Team-Based Learning
Team-Based Learning in Pharmacy Education
Team-Based Learning: Windfalls and Pitfalls
Integrating Team-Based Learning and High-Fidelity Simulation for Interprofessional Education
Optimizing Student Engagement with Novel TBL Techniques that Get Students Moving
Incorporation of high fidelity simulation learning experiences within a didactic and experiential curriculum
A field guide for transforming your *yawn* clinical lectures into a lively team-based learning (TBL) classroom
Leadership and Quality (Student Body Council Retreat Workshop)
Continuous Formative Assessment of Team-Based Learning: RATs, BATs, and CATs
Comparing a Simulation Based Introductory Pharmacy Practice Experience (IPPE) to Traditional Direct Patient Care IPPEs
Pathways to Expand the Effectiveness of Teaching and Learning: A workshop for educators to engage active learning strategies and explore team-based learning (TBL)
Introduction to TBL Workshop
Team-Based Learning Primer Workshop
Faculty Orientation to Team-Based Learning
Focus on Quality (University Retreat Workshop)
New Student Orientation to Team-Based Learning
Personal Information: Born in Portland Oregon, Living in Clovis, Husband to Amy, Father to Apollo and Orion.
Come to me for ...
•
Faculty peer assessment of facilitation, course materials, examinations
•
Support in designing and implementing educational scholarship
•
Curriculum and assessment design and alignment with outcomes using backward design principles
•
End of semester student peer evaluation and team roles
•
All things TBL, IPE, and process education
•
TA and new faculty development
•
Help with alternative progression plans
College of Pharmacy
Office of the DeanAdmissionsAssessment and Program ExcellenceExperiential EducationFinancial AidInterprofessional Community EngagementRegistrarStudent AffairsClinical Sciences DepartmentPharmaceutical and Biomedical Sciences DepartmentSocial and Economic Sciences Department
Wendy Duncan, PhD (Pharmaceutics)
Senior Vice President for Academic Affairs and Provost Dean, College of Pharmacy 559-325-3600 wduncan@chsu.edu
Biography
Wendy Duncan, PhD, is a distinguished expert in new program evaluation and development and curriculum design and assessment. With extensive experience in strategic planning and change management, she is a visionary with a passion for developing innovative learning and scholarly opportunities for students. Prior to joining CHSU, Dr. Duncan served as Dean in the College of Pharmacy and Health Sciences and Professor at Drake University in Des Moines, Iowa and as Vice President of Academic Affairs, Dean of Pharmacy, and Professor at St. Louis College of Pharmacy. Prior to her appointment as Dean, she served as a faculty member at the University of Toronto and as Associate Dean for Education and Director of the Office of Teaching, Learning and Assessment at Auburn University’s Harrison School of Pharmacy. Duncan received her Bachelor of Science in Pharmacy and PhD in Pharmaceutics from the University of Toronto.
At both St. Louis College of Pharmacy and Auburn University Harrison School of Pharmacy, Duncan instituted curricular transformation with the extensive use of team-based and problem-based learning and a greater focus on practice management, advocacy and community service. Duncan has demonstrated her comprehensive understanding of accreditation procedures through the successful completion of self-studies resulting in accreditation and reaccreditation at four institutions at both the programmatic and regional level and by serving as a site evaluator for the American Council for Pharmaceutical Education since 2007. Duncan also conveys a strong focus on intra- and inter-professional coalitions and research and she formally instituted the Des Moines Area Interprofessional Collaborative among five colleges and universities. She was instrumental in amassing the Missouri Pharmacy Coalition, a consortium of colleges, state pharmacy organizations and board members creating a legislation- and policy-focused alliance. She was responsible for developing inter-professional alliances with Saint Louis University, Washington University School of Medicine, and Goldfarb School of Nursing providing new educational, practice, and research opportunities for students and faculty.
Come to me for ...
•
Clarification on things that are confusing or potentially concerning
•
Ideas for collaboration, communication and possible issues with administration, both at COP and at University or other colleges
•
Sharing strategic ideas
•
Sharing ideas to improve just about anything, especially communication
•
Accreditation (with leadership support from Dr. Fuentes)
•
Questions about or issues with university governance
•
Systems issues or failures
•
Requests to participate in initiatives, events, or committees
•
Resource needs at the college or university level
David G. Fuentes, PharmD, MSOL, SHRM-CP, EdD.c.
Executive Associate Dean, College of Pharmacy Chair, Clinical Sciences and Professor 559-546-6049 dfuentes@chsu.edu
Dr. David Fuentes brings deep knowledge in higher education with experiences in strategic planning, faculty development, mentorship, programmatic assessment, accreditation, instructional design, educational psychology, curricular design/redesign, and organizational leadership. Dr. Fuentes has worked up the ranks in academia in various faculty and administrative roles including: founding faculty member, department chair for pharmacy practice, interim department chair for pharmaceutical & administrative sciences, assistant dean for academics and assessment, and university-level interim chief diversity officer. He has been recognized for excellence in teaching within his programs, and from the American Association for Colleges of Pharmacy (AACP) for excellence in assessment. Dr. Fuentes has clinical certifications as a geriatric and psychiatric specialty pharmacist, and has earned professional certifications as a Gallup strengths coach, six sigma lean systems black belt, and human resources professional. He has also completed various leadership workshops and two formal training programs through AACP’s Academic Leadership Fellows Program and the American College of Clinical Pharmacy’s (ACCP) Leadership and Management Certificate Program, using this collective expertise to actively consult for various organizations in diverse industries on systems processes, talent development, personnel review processes, arbitration and team dynamics, personality test debriefs, and strategic planning.
In teaching, Dr. Fuentes has experience providing instruction to multiple professional/graduate students in the areas of pharmacy, physician assistant studies, psychology, healthcare administration, and dental health sciences, as well as in various inter-professional courses. He has coordinated various courses and is a proponent for active learning, learner engagement and motivation, and assessment of student learning.
Related to scholarship, Dr. Fuentes has published in the areas of public health, research compliance processes, inter-professional education, pharmacists’ awareness of differential diagnostics, team-based learning, integrated teaching, leadership development, reflective portfolios, and experiential education, among other areas.
Pertaining to service, Dr. Fuentes has been involved with national organizations in various roles and capacities including: special interest group (SIG) chair elect and chair, taskforce member, nominations committees, academic committees, scholarship groups. He is involved with the AACP Continuing Professional Development (CPD) section and Social Administrative Sciences (SAS) section, as well as the ACCP Education and Training section. He has also served as an expert witness to district attorneys, legal offices, social workers, and forensic specialists in various cases.
Dr. Fuentes received his Doctor of Pharmacy degree from Thomas J. Long School of Pharmacy and Health Sciences, and completed a Pharmacy Practice Residency at St. Joseph’s Medical Center. A life-long learner, he is currently enrolled at Southern New Hampshire University in a master of science-level program in organizational leadership.
Working closely with course directors, faculty advisors and the registrar, Rosemary effectively, efficiently, proactively, and responsively manages academic affairs and related processes for the College of Pharmacy. Rosemary ensures that our students progress smoothly through the program according to policy and plan.
Come to me for ...
•
RxPrep support
•
Promediation and at-risk students
•
Teaching Assistants and Tutoring Program for the College of Pharmacy
•
Focus groups
•
Classroom setup
•
Curriculum support specific to COP (including brightspace, grades, and exams)
Assistant Dean for Student Affairs and Enrollment Assistant Professor of Clinical Sciences 559-546-6049 jhughes@chsu.edu
Department: Clinical Sciences
Year Began at CHSU: 2017
Current Classes Taught:
• PHR 645: Patient Care II (topics include Benign Prostatic Hypertrophy, Urinary Incontinence, and Erectile Dysfunction)
Education:
• Washington State University, Doctor of Pharmacy
• Washington State University, Bachelor of Science in Psychology
Professional Affiliations:
• American Association of Colleges of Pharmacy (AACP)
• APhA (and WSPA, OSPA)
• ASHP (and OSHP)
Professional Service:
• Student Services SIG Chair-Elect, AACP
Experience:
• Assistant Dean for Student Affairs and Assistant Professor, Pacific University School of Pharmacy
• Director of Experiential Education and Assistant Professor, Pacific University School of Pharmacy
• Coordinator for Experiential Advancement and Assistant Professor, Pacific University School of Pharmacy
Latest Projects & Publications:
• Darbishire PL, Devine PS, Proctor AJ, Horner WJ, Hoffmann EM, Ott CA, Fuentes DG, Hughes JA. National Survey Exploring Drug Screening in Pharmacy Programs. Am J Pharm Educ. Posted online on Sept 29, 2017.
• Hughes JA, Cleven AJ, Ross J, Fuentes DG, Elbarbry F, Suzuki M, Della Paolera MA, Carter NS, Stamper BD, Low P, Malhotra A, Faro SJ. A Comprehensive Reflective Journal-Writing Framework for Students to See their Experiences through Diverse Lenses and Develop Actionable Goals. Am J Pharm Educ. Posted online on Sept 25, 2017.
• Hughes J, Della Paolera M, Stalvey K, Madu C, Rao D, Devaud L, Doyle I, Roberts S, Fuentes D. (2016). Mentorship at All Levels: A Culture of Mentorship in a Health-Professions Degree Program. In Dominguez, N. & Alexander, D. (Eds.), 9th Annual Mentoring Conference Proceedings: Developmental Networks: The Power of Mentoring and Coaching. University of New Mexico, Albuquerque, NM.
• Hughes J, Fuentes D, Gundersen D. Formalizing a Mentorship Program Between Graduate/Professional and Undergraduate Students to Increase Admissions, Retention, Professionalism, and Engagement. Pacific University Intercollegiate Collaborative Grant:, Forest Grove, OR
Personal Information:
• Dr. Hughes graduated with his PharmD from Washington State University in 2002, and has a background in independent and compounding pharmacies. Before pursuing a full-time career in academia, he served as a preceptor and Clinical Affiliate Faculty Member for Washington State University, Oregon State University, and Pacific University. He has also worked in a variety of settings including veterinary pharmacy, independent pharmacy, compounding pharmacy, chain pharmacy, and manufacturing.
Assistant Dean for Assessment & Program Excellence and Professor 559-701-2108 mansong@chsu.edu
Biography
By ensuring that the assessment plan is fully delegated, monitored, implemented, and documented, and that there is clarity on what constitutes quality, Dr. Ansong guarantees the improvement and effectiveness of our programs and processes and ensures our compliance with ACPE.
Come to me for ...
•
improving assessment and SII-PDCA submission process
•
Creating and improving assessment and evaluation tools
•
Refining learning outcomes
•
Creating and finding evidence needed for assessment plans and accreditation
•
Ideas and collaboration of signature assignments in courses
Mary Solis, MA, BSN, RN
Director of Experiential Education Assistant Professor of Clinical Sciences 559-573-8121 msolis@chsu.edu
Biography
Ms. Solis ensures that we have an experiential program that provides rich learning and developmental experiences for our APPEs and IPPEs students and that those experiences are equivalent among sites and preceptors. Assessment of the effectiveness of the APPE and IPPE is highly integrated into the role for the DEE. This is accomplished through site and preceptor selection, assessment, and development. Developing, nurturing, and growing relationships is an integral part of this role.
Come to me for ...
•
All issues with IPPE or APPE students
•
Rotation support for students, preceptors, and faculty
•
Preceptor and faculty training
•
Student schedules for APPEs or IPPEs, as well as any changes or assignments
•
Sharing ideas on potential preceptors or sites we can approach and grow relationships
7/1985 - 6/1986 Clinical Pharmacy Residency, University of California San Francisco (UCSF), San Francisco, CA
8/1982 -4/1985 Pharm.D., University of the Pacific (UOP), School of Pharmacy, Stockton, California
9/1977-6/1981 B.S. Physiology, University of California Davis (UCD), Davis, California
Professional Affiliations: • California Pharmacists Association (CPhA) • Central Valley Pharmacists Association (CVPhA) • American College of Clinical Pharmacy (ACCP) • American Academy of Colleges of Pharmacy (AACP) • American Society of Microbiology (ASM) • Infectious Diseases Society of America (IDSA) • Society of Infectious Disease Pharmacists (SIDP) • American Association of Advancement of Science (AAAS)
Professional Service:
3/2015 - Present CPhA Academy Board of Directors, Pharmacy Education
1/2015 - Present CAPSLEAD Faculty Advisor for CHSU
1/2009 –1/2012 Board Certified Educator Contributor Pharmacotherapy Self-Assessment Program for Board Certification American College of Clinical Pharmacy
6/1996 – 5/1997 AACP, Professional Affairs Committee (Member)
10/1995 – 9/1996 SIDP, Awards Committee (Member)
10/1993 – 10/1994 SIDP, Nomination and Election Committee (Member)
5/1991 – 12/1995 American Society of Hospital Pharmacists (ASHP), Education Programming Associate
5/1991 – 5/1993 ACCP, Public and Professional Relations Committee (Member)
3/1991- 12/1992 ACCP, Membership and Resolutions Committee (Member)
Fundraising Events for the HIV High-Risk Pregnancy Program:
3/2004 – 12/2004 Emerging Artist Showcase: Artists for a Cure, with Rory Kennedy as Keynote Speaker
Journal Review :
8/2008 - Present Journal of Obstetrics and Gynecology Research
5/2008 - Present American Journal of Pharmaceutical Education
5/2003 - Present Journal of Reproductive Medicine Pharmacotherapy Annals of Pharmacotherapy
4/2001 - Present American Journal of Obstetrics and Gynecology
11/1997 - Present Journal of Infectious Disease Pharmacotherapy
3/1994 - Present Clinical Infectious Diseases The Annals of Pharmacotherapy
Professional Experience:
3/01/2012 - 6/2014 Interprofessional Education, Director School of Pharmacy and Pharmaceutical Sciences & Academic Health Centers University of Buffalo, Amherst, NY 14260-1200
1/01/11-3/31/2013 Interim Associate Dean Academic Affairs School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
2/2007 – Present Associate Professor Visiting Scholar Shanghai Public Health Clinical Center Affiliation to Fudan University Jinshan District, Shanghai
7/2006 – 12/31/09 Division Head, Pharmacotherapy Research Programs School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
7/2006 – 6/2014 Associate Professor School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
7/2001 – 8/2006 HIV High Risk Pregnancy Research and Education Coordinator The Department of OB/GYN, The OSU Medical Center, Outpatient Clinic, Columbus, OH
3/2003 - Present Associate Professor, Maternal Fetal Medicine Department of OB/GYN The Ohio State University
7/1997- 7/2006 Associate Professor of Division of Pharmacy Practice & Administration, College of Pharmacy, the Ohio State University, Columbus, OH 43210
1/1994 –7/1997 Assistant Professor of Division of Pharmacy Practice & Administration, College of Pharmacy, the Ohio State University, Columbus, OH 43210
8/1989 -12/1993 Clinical Specialist Consultant Infectious Diseases, Pharmacy Service, Department of Veterans Affairs Medical Center, East Orange, NJ
8/1988 – 8/1989 Clinical Pharmacist in Infectious Diseases Department of Veterans Affairs Medical Center East Orange, NJ
8/1988 – 12/1993 Assistant Professor of Pharmacy Practice, Depart of Pharmacy Practice and Administration, College of Pharmacy, Rutgers University, Piscataway, NJ
Awards:
4/2011
Faculty Service Award, Phi Lambda Sigma, University at Buffalo
4/2010
Pharmacist of the Year, Lambda Kappa Sigma Advancement for Women Pharmacist Organization, University at Buffalo
5/2006
Multicultural Faculty of the Year, OSU Multicultural Center
10/1992
Honorary Faculty Member, Phi Lambda Sigma, Lambda Chapter, Rutgers College of Pharmacy
5/1991
William Levine Teacher of the Year Award
4/1990
Outstanding Teacher of the Year, Presented by the Parents Association of Rutgers University
8/1989
Incentive Performance SES Award, Department of Veterans Affairs Medical Center East Orange, NJ
4/1985 - present
Rho Chi Honor Society
4/1985
The Merck Award, Best Externship Project Award
12/1983
J. Patrick Gould Award
Grants:
1/05/2013 - 12/31/2015
$15,000.00 from Center for Advanced Functional Foods Research and Entrepreneurship and The Molecular Carcinogenesis and Chemoprevention Program, of The Ohio State University Comprehensive Cancer Center Request for Applications Diet, Nutrition and Cancer Research Awards, “Nanoemulsion curcumin for obesity, inflammation and breast cancer prevention – a pilot trial”. Role Co-I The primary objectives of this study are to determine the adherence, tolerability and safety of two doses of nanoemulsion curcumin (NEC) in women at high risk for developing breast cancer, and to determine whether NEC modulates pro-inflammatory biomarkers in plasma and breast adipose tissue.
7/01/2012 - May 2014
$13,190.36 in in-kind services from the CRC on your pilot study (PHARM46), “Single dose pharmacokinetics of Meriva and nanoemulsified curcumin (NEC) and short term safety of NEC in 10 healthy volunteers.” Role Co-I To evaluate the pharmacokinetics of Meriva (gold standard curcumin product with enhanced curcumin absorption) and NEC at a bioequivalent dose in 10 healthy volunteers.
Nov. 2010 - April 2011
$8,793.57 in in-kind services from the CRC on your pilot study (PHARM42), “A pilot study to evaluate the pharmacokinetics of standard curcumin and curcumin gel in four healthy volunteers.” Role Co-I The purpose of the study is to assess the pharmacokinetics and safety of standard curcumin and a novel curcumin gel formulation in healthy volunteers
Nov. 2008 - March 2011
$81,627.29 Abbott Laboratories: The function of P-glycoprotein in the intracellular disposition of lopinavir/ritonavir in peripheral blood mononuclear cells between maternal and fetal compartments.d Role: PI To semi-quantitate the mRNA expression of ABCB1 between maternal cord blood PBMCs using realtime-PCR.
Dec. 2006
$8, 638 funding from Beth Israel Deaconess Medical Center for Transplacental Distribution of Penicillin in Pregnant Women with Group B Streptococci Screening.f Role Co-I To measure maternal and cord blood penicillin levels and to determine the transplacental distribution of pencillin in pregnant women with positive Group B Streptococci screening.
October 2005
$5,000 unrestricted grant from Pfizer for “Pharmacy-Based Cultural Competence in Health Care”
Oct. 2004 - Sept. 2007
$100,000 from the Southwest National Primate Research Center/National Institute of AIDS Research (NIH grant P51 RR13986) for study entitled, “The effects of pregnancy on the PK of anti-HIV drugs in a baboon model.e PI: Patty Fan-Havard, Co-I: Richard O’Shaunghnessy, M.D. Kenneth Chan, Ph.D., and Saj Joy, M.D." The purpose of the study is to characterize and compare the pharmacokinetics of nevirapine at different stages of pregnancy and postpartum in a baboon model and to determine the feasibility of using baboons for obstetric-fetal pharmacology studies.
7/01/03 - 6/30/06
$5,000 HRSA (CRI#H819003): Family-Centered, Community-Based, Coordinator HIV Care Programs (FACES) PI: Michael T. Brady, M.D. Co-I: Patty Fan-Havard, Pharm.D. The HIV High-Risk Pregnancy Clinic, in collaboration with the Family AIDS Clinic and Education Services (FACES) Program at Columbus Children’s Hospital, is a multidisciplinary outpatient program for pregnant women with HIV-1 Infection. It provides comprehensive, prenatal, obstetrical and medical care, health and medication education and chemical dependency counseling. Newborns and mother are referred to the FACES Program postpartum for comprehensive pediatric and maternal continuum care.
Sept. 2000 - Aug 2002
$55,000.00 from the American Foundation for Pharmaceutical Education for study entitled, “A pilot study to establish an in vitro and in vivo model applicable to evaluate placental steroidogenesis and placental distribution of nelfinavir."d PI: Patty Fan-Havard Co-I: Douglas A. Kniss, Ph.D.
Sept. 2000 - Aug. 2001
$18,500.00 from the Society of Infectious Diseases Pharmacists for study entitled, "Determination of nelfinavir binding to cellular retinoic acid-binding protein (CRABP1) in placental trophoblasts.."d PI: Patty Fan-Havard, Co-I: Douglas A. Kniss, Ph.D.
Sept. 1995
$19,554.00 from the Society of Infectious Diseases Pharmacists for study entitled, "Cytokine release with amphotericin B from Cryptococcus neoformans infected astrocytes."d
April 1995
$36,003.00 from American Association of Colleges of Pharmacy (AACP) for study entitled "A hospital based project for developing a continuity of pharmaceutical care discharge plan for patients with AIDS requiring home infusion therapy."d
July 1992
$10,000.00 from Centocor for evaluating the clinical trial entitled, "Centocor HA-1A efficacy in septic shock trial (CHESS Trial)."b
June 1992
$1,000.00 funding support from Amgen for the Postdoctoral Infectious Disease Fellowship program, Rutgers University, College of Pharmacy.a
April 1993
$25,538.00 from Bristol Myers Squibb for evaluating pharamcokinetic study entitled, "Open-label study of cefepime into the CSF of subjects with non-inflamed meningitis."b
Feb. 1993
$20,000.00 from Pfizer Pharmaceuticals for conducting the clinical trial entitled, "Randomized, placebo-controlled trial of E5 monoclonal antibody in patients with severe sepsis."b
April 1992
$400.00 funding from the Foundation of Pharmacists & Corporate America for AIDS for the protocol entitled, "The impact of Pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."c
March 1992
$85,000.00 from Janssen Research Foundation for evaluating the clinical trial entitled, "Double-blind, randomized, comparative study of itraconazole and fluconazole as maintenance therapy for preventing relapse of AIDS related cryptococcal meningitis."b
March 1992
$85,000.00 from Janssen Research Foundation for evaluating the clinical trial entitled, "Randomized, comparative study of Itraconazole and Fluconazole for the treatment of AIDS related Cryptococcal meningitis."b
Feb. 1992
$400.00 funding from the Foundation of Pharmacists & Corporate America for AIDS for the protocol entitled, "The impact of Pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."c
Dec. 1991
$100,000.00 grant from Bristol Myers Squibb for evaluating the clinical trial entitled, "An open-label multi-investigator comparative study of the safety and efficacy of cefepime and ceftizidime in the treatment of hospitalized patients with septicemia."b
March 1991
$2,000.00 Merck Education Grant for study entitled, "The impact of pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."b
Jan. 1991
$5,700.00 grant from Bristol Myers Squibb for evaluating the pharmacokinetics of cefepime in septicemic patients.a
Jan. 1991
$65,500.00 grant from Bristol Myers Squibb for clinical study entitled, "A study of cefepime in the treatment of serious bacterial infections particularly those caused by Staphylococci, Pseudomonas, and other less common gram-negative bacilli."a
July 1990
$31,000.00 grant from Abbott Laboratories for evaluating the efficacy and safety of temafloxacin vs. ceftazidime in the treatment of bacterial pneumonia in hospitalized patients.b
June 1990
$22,080.00 grant from Bristol Myers Squibb for determining the pharmacokinetics of cefepime in seriously-illed patients.a
Jan. 1990
$77,280.00 grant from Bristol Myers Squibb for a clinical study entitled, "A clinical study on the efficacy and safety of cefepime in the treatment of bacterial endocarditis including patients who are intravenous drug abusers."a
Dec. 1989
$2,000.00 awarded from Rutgers University Research Foundation for study protocol entitled, "A pharmacokinetic study on the brain tissue concentrations of antimicrobial agents in a rat model."a
"a" = Funds deposited at Rutgers University "b" = Funds deposited at the Veterans Biochemical Research Institute Department of Veterans Administration Medical Center, East Orange, NJ "c" = Funds deposited in the Academy of Students of Pharmacy (ASP) "d" = OSURF “e” = Southwest National Primate Research Center (SNPRC) “f” = University at Buffalo, The State University of New York
Latest Projects:
In her new position at the CHSU, Dr. Havard’s major academic responsibilities are to 1) establish and promote co-curricular activities and entrustable skills development for pharmacy students, and student scholarship mentoring programs; and, 2) coordinate the interprofessional education program and intercollaborative practice initiatives thru co-curricular activities at CHSU.
Her clinical research interests include 1) clinical efficacy and safety of curcumin in the treatment of aromatase-inhibitors-induced arthralgia in women with breast cancer; 2) characterization of drug-herb interactions of curcumin and anti-retroviral agents in HIV-infected patients; and, 3) student learning outcomes through co-curricular activities.
Peer-Reviewed Publications:
1)
Ho MJ, Chan E, Fan-Havard P, Thompson C, Hess JM. The Effects of Leadership Involvement and Part-time Employment on Pharmacy Student Academic Performance. Pharmacy Education 2014;14. (Access: http://pharmacyeducation.fip.edu/2014/05).
2)
Fan-Havard P, Zhongfa Liu, Monidarin Chou, Yonghua Ling, Aurélie Barrail-Tran, David W. Haas, Anne-Marie Taburet, and the ANRS12154 study group. "Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state" Antimicrob. Agents Chemother 2013; 57(5):2154-60. PMID: 23459477)
3)
Schmouder VM, Prescott GM, Franco A, Fan-Havard P. The Rebirth of Progesterone in the Prevention of Preterm Labor. Ann Pharmacotherapy 2013 47(4):527-36. (PMID:23535817)
4)
Chen W, Fan-Havard P, Yee LD, Cao Y, Stoner GD, Chan KK, Liu Z. A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2012;900:89-93. (PMID 22682887).
5)
Liu Z, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 2012, 69(3):679-89. (PMID 21968952)
6)
Chen R, Fan-Havard P, Schlabritz-Loutsevitch N, Chan KK, Liu Z. A Sensitive and Specific Liquid Chromatography/Tandem Mass Spectrometry Method for Quantification of Nevirapine and Its Five Metabolites and Their Pharmacokinetics in Baboons. Biomedical Chromatography 2010;24(7): 717-26 (PMID:19882749).
7)
Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, Huang TMC, Marcucci G, Chan KK. Quantification of Regional DNA Methylation by Liquid Chromatography/Tandem Mass Spectrometry. Analytical Biochemistry 2009;391(2):106-113.
8)
Joy SD, O’Shaughnessy R, Schlabritz-Loutsevitch N, Leland MM, Frost P, Fan-Havard P. Fetal Blood Sampling During the Second and Third Trimester in Baboons. J Med Primatol 2009;38(3):151-55.
9)
Liu Z, Fan-Havard P, Xie Z, Ren C, and Chan KK. A Liquid Chromatography/atmospheric Pressure Ionization Tandem Mass Spectrometry Quantitation Method for Nevirapine and Its Two Oxidative Metabolites, 2 Hydroxynevirapine and Nevirapine 4-Carboxylic Acid, and Pharmacokinetics in Baboons. Rapid Commun Mass Spectromet 2007;21:2734-42.
10)
Colombo DF, Lew JL, Pedersen CA, Johnson JR and Fan-Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus. Am J Obstet Gynecol; 2006;194:466-70.
11)
Fan-Havard P. Vision of Life: A lesson learned from a 98-year old artist on World AIDS Day. Ann Pharmacother 2005;39;2111-3.
12)
Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, and Fan-Havard P. Third trimester maternal toxicity with nevirapine use in pregnancy. Obstet & Gynecol 2005; 106:1032-1038.
13)
Hua Y, Fan-Havard P, Chan KK, and Liu Z. A subnanogram on-line column-switch LC/MS/MS quantitation method for nelfinavir and methoxy-phenol metabolite M1 in rat plasma. J Chromatograph B 2004;809:1-7.
14)
Knudtson E, Para M, Boswell H and Fan-Havard P. DRESS syndrome and renal toxicity with nevirapine-containing regimen in a pregnant patient with HIV. Obstet Gynecol 2003;101:1094-1097.
15)
Kniss DA, Sargent IL, Xie Y, Li Y, Kumar S, Linton E, Cohen P, Fan-Havard P, Redman CWG and Sargent IL. ED27 trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta 2002, vol 23(1):32-43.
16)
Johnson JR, Colombo DF, Gardner D, Cho E, Fan-Havard P and Shellhaas. Optimal penicillin dosing for Group B Streptococcus prophylaxis. Am J of Obst & Gyn 2001 185(4):850-3.
17)
Kendle JB and Fan-Havard P. Cidofovir in the treatment of Cytomegaloviral Disease. Ann Pharmacother 1998;32:1181-92.
18)
Fan-Havard P, Kucukarslan S, Legg J, Russell F, Laurila TL, Berger MJ, Green SK and Pathak D. Continuity of pharmaceutical services for patients with AIDS in the transition from hospital to home. Am J Health-Syst Pharm 1997;54:1407-12.
19)
Sharkey-Mathis PK, Graybill JR, Johnson ES, Hausrath SG, Pollard R, Mildvan D, Fan-Havard P, Eng RHK, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Silverman E and Gordon D. Amphotericin B lipid complex (ABLC) compared to amphotericin B in treatment of cryptococcal meningitis in AIDS patients. Clin Infect Dis 1996;22:315-321.
20)
Fan-Havard P, O'Donovan CA, Smith SM, Oh J, Bamberger MH and Eng RHK. Comparison of oral fluconazole with amphotericin B bladder irrigation for treatment of candidal cystitis. Clin Infect Dis 1995;21:960-5.
21)
O'Donovan CA, White ML, Cheung A, Fan-Havard P. A retrospective review of the incidence of seizures with imipenem therapy. Hosp Formulary 1995;30:172-5.
22)
Fan-Havard P, Sanchorowala V, Oh J, Moser E, Smith SP. Concurrent use of foscarnet and ciprofloxacin may increase the propensity for seizures. Ann Pharmacother 1994;28:869-72.
23)
O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RHK. Enteric eradication of Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105-9.
24)
Fan-Havard P, Koshy Z, Bais RM, Smith C, Eng RHK. A comparative pharmacokinetic study of teicoplanin in morphine pretreated, phenobarbital pretreated and control rats. J Antimicrob Chemother 1993;32:101-108.
25)
Fan-Havard P, Eng RHK, Frenia M, Smith SM, Akgun R, Pinto-Powell R. Peripheral leukocytosis and Clostridium difficile colitis. Turkish J Med Sci 1993;17:37-44.
26)
Eng RHK, Smith SM, Fan-Havard P, Ogbara TJ. The effect of antibiotics on the release of endotoxins. Diagn Microbiol Infect Dis 1993;16:185-189.
27)
Fan-Havard P, Yamaguchi E, Smith SM, Eng RHK. Diastolic hypertension in AIDS patients with Cryptococcal meningitis. Am J Med 1992;93:347-8.
28)
Fan-Havard P. Accredited Continuing Education for LV/PN :Pneumocystis carinii pneumonia in AIDS patients. J Practical Nursing 1992;June:52-62.
29)
Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RHK. Resistance development among Candida isolates from patients on prolonged antifungal therapy. Antimicrob Agents Chemother 1991;35:2302-2305.
30)
Eng RHK, Lynch AM, Smith SM, Ambros RA, Fan-Havard P, Mangia A, Tecson-Tumang F, Cherubin C. Imipenem resistance in a case of AIDS with relapsing Pseudomonas meningitis. South Med J 1990;83:979-980.
31)
Smith SM, Bais P, Eng RHK, Fan-Havard P, and Tecson-Tumang F. Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. J Antimicrob Chemotherapy 1990;26:567-72.
32)
Nahata MC, Fan-Havard P, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of intravenous rifampin in pediatric patients undergoing CSF shunt placement. Eur J Clin Pharmacol 1990;38:515:17.
33)
Fan-Havard P. Accredited Continuing Education: Pneumocystis carinii pneumonia in AIDS patients. Pharmacy Times 1990;56:108-21.
34)
Nahata MC, Fan-Havard P, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid CSF) concentrations of nafcillin in pediatric patients undergoing CSF shunt procedure. Chemotherapy 1990;36:98-102.
35)
Fan-Havard P, Nahata MC, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy 1990;36:103-8.
36)
Smith SM, Eng RHK, Bais P, Fan-Havard P. Development of ciprofloxacin-resistant methicillin resistant Staphylococcus aureus during therapy. E. Lewin-Epistein Ltd., Jerusalem. 1989;672.1-672.
37)
Fan-Havard P, Nahata MC and Brady M. Ganciclovir: A review of pharmacology, therapeutic efficacy, and potential use for treatment of congenital cytomegalovirus infection in children. J Clin Pharm Therap 1989;14:329-40.
38)
Fan-Havard P, Nahata MC. A rapid analysis of nafcillin using high performance liquid chromatography. Therap Drug Monit 1989;11:105-8.
39)
Fan-Havard P, Nahata MC, Barson W, Bartkowski H, and Kosnik E. Histamine-like reaction following a single dose of intravenous rifampin. Clin Pharm 1988;7:616-20.
40)
Fan-Havard P, Nahata MC. Treatment and prevention of cerebrospinal fluid shunt infections. Clin Pharm 1987;6:866-80.
Book Chapters (peer-reviewed)
1)
Fan-Havard P and Lamberjack K. PSAP VII. Women’s and Men’s Health. Special Considerations for HIV in Women. In: Pharmacotherapy Self-Assessment Program VII. Book 6. 2010:pp 43-67. Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook A Patient-Focused Approach, 5th Edition. McGraw-Hill Company, Inc., New York, 2002: pp:345-347.
2)
Crutchley R, Brilliant A, Fan-Havard P, Morse G. Maraviroc. In: HIV Clinical Manual, 1st Edition. Eds Singh N, Shafer RW, and Swindells S. (Epub: Section II, Antiretroviral Therapy, Part B. Anitretroviral Agents. Access: Antimicrobe.edu). ESun Technologies, LLC., Pittsburg, PA.
3)
Fan-Havard P and Zabawski EJ. Cidofovir. In: Antimicrobial Therapy and Vaccines: Volume II: Antimicrobial Agents, 2nd Edition. Eds Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse G. ESun Technologies, LLC., Pittsburg, PA. 2005: pp:731-745.
4)
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook A Patient-Focused Approach, 6th Edition. McGraw-Hill, Company, Inc., New York, 2005: pp:352-354.
5)
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook: Instructor’s Guide, 5th edition. McGraw-Hill Company, Inc., 2002: Available on CD-ROM (ISBN: 0-07-140684-0).
Abstracts and Scientific Presentations (Selected 15 of 56 abstracts and scientific presentations):
1)
“Successful implementation of intercollaborative practice experience to prepare pharmacy students for the Advanced Practice Pharmacists Skills under SB 493.” Accepted to the 2016 CPhA West Coast Exchange Annual Meeting April 28-30th, 2016, San Francisco, CA.
2)
Hudspeth J, Ibrahim H, Phanthachack L, Tyner T, Trueblood PR, and Havard P. Intercollaborative Integration of Pharmacy Students to Improve Medication Reviews in Older Adults with Fall Risks. Accepted to the AACP and AFPC Annual Meeting in National Harbor, MD. July 11th -15th, 2015 National Harbor, Maryland.
3)
Ohtake PJ, Fish DR, Wietig PT,Lucke KT, Fan-Havard P, Antonson D, Ellis A, Elze D, Fiebelkorn K. What’s Good for the Goose is Good for the Gander: Using an Interprofessional Leadership Approach to Develop a University IPE Curriculum. Presented as a poster presentation at the Collaborating Across Borders (CAB) IV and Interprofessional Collaboration: Transformative Change from the Classroom to Practice, June 12th-14th, 2013, Vancouver, BC, Canada.
4)
Lucke KT, Ellis A, Fan-Havard P, Elze D, Ohtake PJ, Antonson D, K Fish DR, Fiebelkorn, and Wietig PT. From Classroom to Community: Building Social Accountability in Health Professions’ Education and Collaborative Practice. Presented as an oral presentation at the Collaborating Across Borders (CAB) IV and Interprofessional Collaboration: Transformative Change from the Classroom to Practice, June 12th-14th, 2013, Vancouver, BC, Canada.
5)
Fan-Havard P, Liu Z, Chou M, Ling Y, Barrail-Tran A, Haas D, Taburet AM, and ANRS 12154 Study group. “Different Nevirapine Metabolite Profiles with Single-dose and at Steady-state". [Abstract N112] Presented at the 2012 19th CROI meeting in Seattle Washington, USA. March 5-8, 2012.
6)
Drozdowicz M, Jaenecke K, Tong A, Franco A, Ramirez N, Barr T, Beyer W, Brazeau D, Fan-Havard P. Aperio ImageScope algorithm: a more sensitive tool in detecting differences in IHC staining intensity of the placental vasculature as compared with visual scoring by a clinical pathologist. Submitted to the 2011 ACCP Annual Meeting, Pittsburg PA Oct 16th – 19th, 2011.
7)
Tong, A, Franco A, Ramirez N, Barr TJ, Beyer W, Brazeau DA, Fan-Havard P. A Pilot Study to Quantitate Placental ß-Catenin Using Morphometric Analysis of Tissue Microarray Sections in Women with Gestational Diabetes, HIV, and Normal Healthy Pregnancies. [Abstract # 305]. Presented at the 2009 Annual Meeting of the American College of Clinical Pharmacy, October 18-21, 2009; Anaheim, CA 2009. Selected Best Student Poster Finalist.
8)
P Fan-Havard, Y Ling, RM Lubin, A Forrest, DW Haas, K Chan, Z Liu. Pharmacokinetics of Nevirapine and its Unglucuronidated Metabolites Following a Single Dose in Healthy African Americans Volunteers. [Abstract #3067 ] Presented at the 5th International AIDS Society July 19th-22nd, 2009 Cape Town, South Africa.
9)
Lubin RM, Tam PY, Brazeau D, Forrest A, Colombo D, Liu Z and Fan-Havard P. The Relationship of ABCB1 Gene Expression and the C3435T and G2677T Polymorphisms between Maternal and Fetal Peripheral Blood Mononuclear Cells (PBMCs) [Abstract 931]. Presented at the 2009 16th CROI meeting, Montreal Canada.
10)
Franco A, Joy S, Kang S, Poi M, Hunkler J, Brady M, Koletar S, Para M, and Fan-Havard P. Maternal and newborn outcomes in a multidisciplinary HIV Pregnancy Program”[Abstract 149] Presented at the 2005 Annual Meeting of the American College of Clinical Pharmacy, October 23-26, 2005, San Francisco, California.
11)
EJ Knudtson, LS Vasist, M Williams, MF Para, MT Brady, and P Fan-Havard. Maternal and Newborn Outcomes Following Implementation of a Multidisciplinary HIV-High Risk Pregnancy Clinic [Abstract no. 373]. Presented at the 2003 Society for Gynecologic Investigation Annual Scientific Meeting, March 27th – 30th, 2003.
12)
Fan-Havard P, Lieb CA, Monahan CM, Cho E, Wymer SK and Richard VB. Nelfinavir (NFV)-Induced Glucose Intolerance in Pregnancy: Placental and Fetal Outcomes in Rats. [Abstract No. 428]. Presentation at the 40th Annual Meeting of the Infectious Diseases of America, Chicago, IL. Oct. 24th-27th, 2002.
13)
Fan-Havard P, Park JL, Park CS and Kniss DA. Characterization of 17-b estradiol biosynthesis in first trimester human placental trophoblasts (ED27). Presented at the 46th Annual Meeting of the Society For Gynecologic Investigation, March 10th-13th, 1999, Atlanta, GA
14)
Al-Haddadon D, Fan-Havard P, Boghossian J, Morton R, Vincent D, Dungo L, Eng RHK, Johnson ES. Amphotericin B lipid complex (ABLC) in the treatment of cryptococcal meningitis in AIDS. [Abstract No. 002344] A World United Against AIDS. VIII International Conference on AIDS/III STD World Congress, Amsterdam, the Netherlands. July 19-24, 1992.
15)
Fan-Havard P, Oh J, O’Donovan CA, Smith SM, Eng RHK, Bamberger MH. Amphotericin B bladder irrigation (AmBBI) vs. Fluconazole (Flu) in the treatment of Candida cystitis. [Abstract No. 631] The 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, California. October 11-14, 1992.
Personal Information:Married to Donald B. Havard and with two beautiful boys, Andrew and Nick Havard. Enjoys golf, photography, “shooting the breeze” with students, and risks aversion when downhill skiing.
Assistant Dean for Student Affairs and Enrollment Assistant Professor of Clinical Sciences 559-546-6049 jhughes@chsu.edu
Biography
Department: Clinical Sciences
Year Began at CHSU: 2017
Current Classes Taught:
• PHR 645: Patient Care II (topics include Benign Prostatic Hypertrophy, Urinary Incontinence, and Erectile Dysfunction)
Education:
• Washington State University, Doctor of Pharmacy
• Washington State University, Bachelor of Science in Psychology
Professional Affiliations:
• American Association of Colleges of Pharmacy (AACP)
• APhA (and WSPA, OSPA)
• ASHP (and OSHP)
Professional Service:
• Student Services SIG Chair-Elect, AACP
Experience:
• Assistant Dean for Student Affairs and Assistant Professor, Pacific University School of Pharmacy
• Director of Experiential Education and Assistant Professor, Pacific University School of Pharmacy
• Coordinator for Experiential Advancement and Assistant Professor, Pacific University School of Pharmacy
Latest Projects & Publications:
• Darbishire PL, Devine PS, Proctor AJ, Horner WJ, Hoffmann EM, Ott CA, Fuentes DG, Hughes JA. National Survey Exploring Drug Screening in Pharmacy Programs. Am J Pharm Educ. Posted online on Sept 29, 2017.
• Hughes JA, Cleven AJ, Ross J, Fuentes DG, Elbarbry F, Suzuki M, Della Paolera MA, Carter NS, Stamper BD, Low P, Malhotra A, Faro SJ. A Comprehensive Reflective Journal-Writing Framework for Students to See their Experiences through Diverse Lenses and Develop Actionable Goals. Am J Pharm Educ. Posted online on Sept 25, 2017.
• Hughes J, Della Paolera M, Stalvey K, Madu C, Rao D, Devaud L, Doyle I, Roberts S, Fuentes D. (2016). Mentorship at All Levels: A Culture of Mentorship in a Health-Professions Degree Program. In Dominguez, N. & Alexander, D. (Eds.), 9th Annual Mentoring Conference Proceedings: Developmental Networks: The Power of Mentoring and Coaching. University of New Mexico, Albuquerque, NM.
• Hughes J, Fuentes D, Gundersen D. Formalizing a Mentorship Program Between Graduate/Professional and Undergraduate Students to Increase Admissions, Retention, Professionalism, and Engagement. Pacific University Intercollegiate Collaborative Grant:, Forest Grove, OR
Personal Information:
• Dr. Hughes graduated with his PharmD from Washington State University in 2002, and has a background in independent and compounding pharmacies. Before pursuing a full-time career in academia, he served as a preceptor and Clinical Affiliate Faculty Member for Washington State University, Oregon State University, and Pacific University. He has also worked in a variety of settings including veterinary pharmacy, independent pharmacy, compounding pharmacy, chain pharmacy, and manufacturing.
Come to me for ...
•
Sharing ideas about students recruitment, interviews, co-curricular activities
•
Participation in pathways and partners events
•
Student support resources and counseling
•
ADA accommodations
•
Advisees or students who have come to you with difficult personal or academic issues
•
Inclusion in CHSU culture for students
•
Student organization oversight and support
•
Events within the college, including white coat and graduation
•
Student leave of absence
•
Issues with participation in interview days
•
Student professionalism issues (less than an academic complaint)
Executive Associate Dean, College of Pharmacy Chair, Clinical Sciences and Professor 559-546-6049 dfuentes@chsu.edu
Biography
Dr. David Fuentes brings deep knowledge in higher education with experiences in strategic planning, faculty development, mentorship, programmatic assessment, accreditation, instructional design, educational psychology, curricular design/redesign, and organizational leadership. Dr. Fuentes has worked up the ranks in academia in various faculty and administrative roles including: founding faculty member, department chair for pharmacy practice, interim department chair for pharmaceutical & administrative sciences, assistant dean for academics and assessment, and university-level interim chief diversity officer. He has been recognized for excellence in teaching within his programs, and from the American Association for Colleges of Pharmacy (AACP) for excellence in assessment. Dr. Fuentes has clinical certifications as a geriatric and psychiatric specialty pharmacist, and has earned professional certifications as a Gallup strengths coach, six sigma lean systems black belt, and human resources professional. He has also completed various leadership workshops and two formal training programs through AACP’s Academic Leadership Fellows Program and the American College of Clinical Pharmacy’s (ACCP) Leadership and Management Certificate Program, using this collective expertise to actively consult for various organizations in diverse industries on systems processes, talent development, personnel review processes, arbitration and team dynamics, personality test debriefs, and strategic planning.
In teaching, Dr. Fuentes has experience providing instruction to multiple professional/graduate students in the areas of pharmacy, physician assistant studies, psychology, healthcare administration, and dental health sciences, as well as in various inter-professional courses. He has coordinated various courses and is a proponent for active learning, learner engagement and motivation, and assessment of student learning.
Related to scholarship, Dr. Fuentes has published in the areas of public health, research compliance processes, inter-professional education, pharmacists’ awareness of differential diagnostics, team-based learning, integrated teaching, leadership development, reflective portfolios, and experiential education, among other areas.
Pertaining to service, Dr. Fuentes has been involved with national organizations in various roles and capacities including: special interest group (SIG) chair elect and chair, taskforce member, nominations committees, academic committees, scholarship groups. He is involved with the AACP Continuing Professional Development (CPD) section and Social Administrative Sciences (SAS) section, as well as the ACCP Education and Training section. He has also served as an expert witness to district attorneys, legal offices, social workers, and forensic specialists in various cases.
Dr. Fuentes received his Doctor of Pharmacy degree from Thomas J. Long School of Pharmacy and Health Sciences, and completed a Pharmacy Practice Residency at St. Joseph’s Medical Center. A life-long learner, he is currently enrolled at Southern New Hampshire University in a master of science-level program in organizational leadership.
Come to me for ...
•
Issues with teaching, research, community engagement, practice and service
•
Interpersonal conflicts
•
Workload and life balance
•
Faculty mentorship and development in all areas of teaching, scholarship, and service
•
Faculty development as clinicians and scientists, as well as career development support
•
Inter-departmental collaborations
•
Inclusion in CHSU culture
•
Liaison between departments and CAC
•
Support and resources at the department level
•
One on your mentors as a member of the department
•
Ways that we can contribute to advancing our disciplines, both internally and externally
•
Budget and purchase requests
•
Departmental mentoring and initiatives in research and scholarship
•
Opportunities for and constraints with engagement in professional, institutional, and/or community service
•
Feedback on and support for performance relative to areas of faculty responsibility that are evaluated annually and for promotion
•
Areas related to faculty workload efforts
Ahmd Azab, PharmD, MS
Vice-Chair & Assistant Professor of Clinical Sciences 559-325-3600 aazab@chsu.edu
Biography
Highly engaged faculty lead to highly engaged students who learn and develop quickly, encountering the fewest unnecessary barriers to learning and success along the way. Dr. Ahmd collaborates with all CHSU stakeholders, and other department heads, to create an academic environment in which faculty and staff are powerfully connected to their colleagues and aligned with the mission of the college — fostering optimal clarity, communication, collaboration, engagement and results at all levels.
Come to me for ...
•
Issues with teaching, research, community engagement, practice and service
•
Interpersonal conflicts
•
Workload and life balance
•
Faculty mentorship and development in all areas of teaching, scholarship, and service
•
Faculty development as clinicians and scientists, as well as career development support
•
Inter-departmental collaborations
•
Inclusion in CHSU culture
•
Liaison between departments and CAC
•
Support and resources at the department level
•
One on your mentors as a member of the department
•
Ways that we can contribute to advancing our disciplines, both internally and externally
•
Budget and purchase requests
•
Departmental mentoring and initiatives in research and scholarship
•
Opportunities for and constraints with engagement in professional, institutional, and/or community service
•
Feedback on and support for performance relative to areas of faculty responsibility that are evaluated annually and for promotion
•
Areas related to faculty workload efforts
Allen Keshishian Namagerdi, PharmD, MS
Academic Fellow & Post-Graduate Instructor of Clinical Sciences 559-573-8122 akeshishian@chsu.edu
Department:
Clinical Sciences
Year Began at CHSU:
2018
Current Classes Taught:
PHR 644: Patient Care I
PHR 746: Patient Care III
Education:
Doctor of Pharmacy 2014-2018 California Health Sciences University, College of Pharmacy Clovis, California
Master of Science in Engineering 1997-1999 University of Tehran, Iran
Bachelor of Science in Engineering 1994-1997 University of Tehran, Iran
Professional Affiliations:
American Association of Colleges of Pharmacy (AACP) • American Society of Health-Systems Pharmacists (ASHP) • California Pharmacists Association (CPhA)
California Society of Health-System Pharmacists (CSHP)
Professional Service:
CHSU California Pharmacy Student Leadership (CAPSLEAD) member (2015-2016)
Student Government Association President, University of Tehran Engineering School (1994-1996)
Experience:
Teacher Assistant, California Health Sciences University College of pharmacy (2015-2018) Clovis, California
Latest Projects & Publications:
Keshishian Namagerdi A, Hussain M.D. Innovative Drug Delivery Approach for Treatment of Brain Cancer. Journal of American Association of Bangladeshi Pharmaceutical Scientists. July 2017: 27-32
Keshishian Namagerdi A, Wang Y, Munjy L, Havard P.
“Administration of Intranasal Naloxone by Law Enforcement Agencies as First Responders”
Presented at American Society of Health System Pharmacists (ASHP) MIDYEAR 2017, Orlando, Florida
Keshishian Namagerdi A, Taylor K, Shah A, Faith O, Shuman H, Mahal H, HU Y.
“Successful Implementation of Inter-collaborative Practice Educational Experiences to Prepare
Pharmacy Students for Advanced Pharmacy Practice Under SB 493”
Presented at California Pharmacy Association West Coast Pharmacy Exchange 2016, San Francisco, CA
Personal Information:
I was born and grew up in Tehran, Iran in an Armenian family. I have lived in Vienna, Austria; Los Angeles; and now I have been living in Clovis, California with my wife Alina and my daughter Anabel since 2014. I completed my PharmD in May 2018 from California Health Sciences University (CHSU) College of Pharmacy (COP) and I was honored by receiving the University’s most prestigious award, the Granville Homes Outstanding Graduate Award. My passion for academic pharmacy persuaded me to start working as a teacher assistant for multiple clinical and pharmaceutical courses when I was student in CHSU and I had the rare opportunity to lead the teaching of several therapeutics, pharmacokinetics, and pharmacology topics during these years. Recent achievements that have resulted from this sustained work include my recognition as CHSU COP 2016 Teaching Assistant of the Year, multiple invited posters and abstracts at national professional conferences, and selection as a 2018 American Association of Colleges of Pharmacy (AACP) Walmart Scholar. I got Academic Fellowship and Post Graduate Instructor position in CHSU College of Pharmacy since July 2, 2018. Also I enjoy spending time with my family, traveling, and playing soccer during my free times.
Professor of Clinical Sciences & Assistant Dean for Assessment and Program Excellence 559-701-2108 mansong@chsu.edu
Sydnei Fox, PharmD
Assistant Professor of Clinical Sciences 559-701-2114 sfox@chsu.edu
Department: Clinical Sciences
Year Began at CHSU: 2018
Current Classes Taught:
PHR 746: Patient Care III
PHR 747: Patient Care IV
Education:
Doctor of Pharmacy
MCPHS University, Boston, MA
Professional Affiliations:
American Society of Health-System Pharmacists (ASHP)
College of Psychiatric and Neurologic Pharmacists (CPNP)
Professional Service:
CAPSLEAD Faculty Advisor
LockItUp Faculty Advisor
Experience:
PGY1 Pharmacy Residency
State Office of Pharmacy Services/CompleteRx, Jamaica Plain, MA
Clinical Staff Pharmacist
Lemuel Shattuck Hospital, Jamaica Plain, MA
Teaching Certificate
MCHPS University, Boston, MA
Latest Projects & Publications:
Meyers, S, Ambury, A, Zhang, A, Lee, R, Abrams, C. Impact of Computerized Prescriber Order Entry on Medication Errors in an Acute Care Hospital. ASHP Midyear Clinical Meeting [Poster]. Orlando, Florida. December 2017.
Personal Information:
I grew up in Massachusetts and have lived in Boston for 10 years until moving to California to join the CHSU team. I have been playing the harp for 16 years and almost went to college for music performance instead of Pharmacy! I enjoy sailing, kayaking, paddle boarding, and being out in nature in general. Especially if my dog can come with me.
My pharmacy practice interests include: HIV/HCV co-infection, intravenous drug use associated infectious diseases, psychiatric pharmacotherapy, and patient safety (especially related to pharmacy informatics.)
7/1985 - 6/1986 Clinical Pharmacy Residency, University of California San Francisco (UCSF), San Francisco, CA
8/1982 -4/1985 Pharm.D., University of the Pacific (UOP), School of Pharmacy, Stockton, California
9/1977-6/1981 B.S. Physiology, University of California Davis (UCD), Davis, California
Professional Affiliations: • California Pharmacists Association (CPhA) • Central Valley Pharmacists Association (CVPhA) • American College of Clinical Pharmacy (ACCP) • American Academy of Colleges of Pharmacy (AACP) • American Society of Microbiology (ASM) • Infectious Diseases Society of America (IDSA) • Society of Infectious Disease Pharmacists (SIDP) • American Association of Advancement of Science (AAAS)
Professional Service:
3/2015 - Present CPhA Academy Board of Directors, Pharmacy Education
1/2015 - Present CAPSLEAD Faculty Advisor for CHSU
1/2009 –1/2012 Board Certified Educator Contributor Pharmacotherapy Self-Assessment Program for Board Certification American College of Clinical Pharmacy
6/1996 – 5/1997 AACP, Professional Affairs Committee (Member)
10/1995 – 9/1996 SIDP, Awards Committee (Member)
10/1993 – 10/1994 SIDP, Nomination and Election Committee (Member)
5/1991 – 12/1995 American Society of Hospital Pharmacists (ASHP), Education Programming Associate
5/1991 – 5/1993 ACCP, Public and Professional Relations Committee (Member)
3/1991- 12/1992 ACCP, Membership and Resolutions Committee (Member)
Fundraising Events for the HIV High-Risk Pregnancy Program:
3/2004 – 12/2004 Emerging Artist Showcase: Artists for a Cure, with Rory Kennedy as Keynote Speaker
Journal Review :
8/2008 - Present Journal of Obstetrics and Gynecology Research
5/2008 - Present American Journal of Pharmaceutical Education
5/2003 - Present Journal of Reproductive Medicine Pharmacotherapy Annals of Pharmacotherapy
4/2001 - Present American Journal of Obstetrics and Gynecology
11/1997 - Present Journal of Infectious Disease Pharmacotherapy
3/1994 - Present Clinical Infectious Diseases The Annals of Pharmacotherapy
Professional Experience:
3/01/2012 - 6/2014 Interprofessional Education, Director School of Pharmacy and Pharmaceutical Sciences & Academic Health Centers University of Buffalo, Amherst, NY 14260-1200
1/01/11-3/31/2013 Interim Associate Dean Academic Affairs School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
2/2007 – Present Associate Professor Visiting Scholar Shanghai Public Health Clinical Center Affiliation to Fudan University Jinshan District, Shanghai
7/2006 – 12/31/09 Division Head, Pharmacotherapy Research Programs School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
7/2006 – 6/2014 Associate Professor School of Pharmacy and Pharmaceutical Sciences University of Buffalo, Amherst, NY 14260-1200
7/2001 – 8/2006 HIV High Risk Pregnancy Research and Education Coordinator The Department of OB/GYN, The OSU Medical Center, Outpatient Clinic, Columbus, OH
3/2003 - Present Associate Professor, Maternal Fetal Medicine Department of OB/GYN The Ohio State University
7/1997- 7/2006 Associate Professor of Division of Pharmacy Practice & Administration, College of Pharmacy, the Ohio State University, Columbus, OH 43210
1/1994 –7/1997 Assistant Professor of Division of Pharmacy Practice & Administration, College of Pharmacy, the Ohio State University, Columbus, OH 43210
8/1989 -12/1993 Clinical Specialist Consultant Infectious Diseases, Pharmacy Service, Department of Veterans Affairs Medical Center, East Orange, NJ
8/1988 – 8/1989 Clinical Pharmacist in Infectious Diseases Department of Veterans Affairs Medical Center East Orange, NJ
8/1988 – 12/1993 Assistant Professor of Pharmacy Practice, Depart of Pharmacy Practice and Administration, College of Pharmacy, Rutgers University, Piscataway, NJ
Awards:
4/2011
Faculty Service Award, Phi Lambda Sigma, University at Buffalo
4/2010
Pharmacist of the Year, Lambda Kappa Sigma Advancement for Women Pharmacist Organization, University at Buffalo
5/2006
Multicultural Faculty of the Year, OSU Multicultural Center
10/1992
Honorary Faculty Member, Phi Lambda Sigma, Lambda Chapter, Rutgers College of Pharmacy
5/1991
William Levine Teacher of the Year Award
4/1990
Outstanding Teacher of the Year, Presented by the Parents Association of Rutgers University
8/1989
Incentive Performance SES Award, Department of Veterans Affairs Medical Center East Orange, NJ
4/1985 - present
Rho Chi Honor Society
4/1985
The Merck Award, Best Externship Project Award
12/1983
J. Patrick Gould Award
Grants:
1/05/2013 - 12/31/2015
$15,000.00 from Center for Advanced Functional Foods Research and Entrepreneurship and The Molecular Carcinogenesis and Chemoprevention Program, of The Ohio State University Comprehensive Cancer Center Request for Applications Diet, Nutrition and Cancer Research Awards, “Nanoemulsion curcumin for obesity, inflammation and breast cancer prevention – a pilot trial”. Role Co-I The primary objectives of this study are to determine the adherence, tolerability and safety of two doses of nanoemulsion curcumin (NEC) in women at high risk for developing breast cancer, and to determine whether NEC modulates pro-inflammatory biomarkers in plasma and breast adipose tissue.
7/01/2012 - May 2014
$13,190.36 in in-kind services from the CRC on your pilot study (PHARM46), “Single dose pharmacokinetics of Meriva and nanoemulsified curcumin (NEC) and short term safety of NEC in 10 healthy volunteers.” Role Co-I To evaluate the pharmacokinetics of Meriva (gold standard curcumin product with enhanced curcumin absorption) and NEC at a bioequivalent dose in 10 healthy volunteers.
Nov. 2010 - April 2011
$8,793.57 in in-kind services from the CRC on your pilot study (PHARM42), “A pilot study to evaluate the pharmacokinetics of standard curcumin and curcumin gel in four healthy volunteers.” Role Co-I The purpose of the study is to assess the pharmacokinetics and safety of standard curcumin and a novel curcumin gel formulation in healthy volunteers
Nov. 2008 - March 2011
$81,627.29 Abbott Laboratories: The function of P-glycoprotein in the intracellular disposition of lopinavir/ritonavir in peripheral blood mononuclear cells between maternal and fetal compartments.d Role: PI To semi-quantitate the mRNA expression of ABCB1 between maternal cord blood PBMCs using realtime-PCR.
Dec. 2006
$8, 638 funding from Beth Israel Deaconess Medical Center for Transplacental Distribution of Penicillin in Pregnant Women with Group B Streptococci Screening.f Role Co-I To measure maternal and cord blood penicillin levels and to determine the transplacental distribution of pencillin in pregnant women with positive Group B Streptococci screening.
October 2005
$5,000 unrestricted grant from Pfizer for “Pharmacy-Based Cultural Competence in Health Care”
Oct. 2004 - Sept. 2007
$100,000 from the Southwest National Primate Research Center/National Institute of AIDS Research (NIH grant P51 RR13986) for study entitled, “The effects of pregnancy on the PK of anti-HIV drugs in a baboon model.e PI: Patty Fan-Havard, Co-I: Richard O’Shaunghnessy, M.D. Kenneth Chan, Ph.D., and Saj Joy, M.D." The purpose of the study is to characterize and compare the pharmacokinetics of nevirapine at different stages of pregnancy and postpartum in a baboon model and to determine the feasibility of using baboons for obstetric-fetal pharmacology studies.
7/01/03 - 6/30/06
$5,000 HRSA (CRI#H819003): Family-Centered, Community-Based, Coordinator HIV Care Programs (FACES) PI: Michael T. Brady, M.D. Co-I: Patty Fan-Havard, Pharm.D. The HIV High-Risk Pregnancy Clinic, in collaboration with the Family AIDS Clinic and Education Services (FACES) Program at Columbus Children’s Hospital, is a multidisciplinary outpatient program for pregnant women with HIV-1 Infection. It provides comprehensive, prenatal, obstetrical and medical care, health and medication education and chemical dependency counseling. Newborns and mother are referred to the FACES Program postpartum for comprehensive pediatric and maternal continuum care.
Sept. 2000 - Aug 2002
$55,000.00 from the American Foundation for Pharmaceutical Education for study entitled, “A pilot study to establish an in vitro and in vivo model applicable to evaluate placental steroidogenesis and placental distribution of nelfinavir."d PI: Patty Fan-Havard Co-I: Douglas A. Kniss, Ph.D.
Sept. 2000 - Aug. 2001
$18,500.00 from the Society of Infectious Diseases Pharmacists for study entitled, "Determination of nelfinavir binding to cellular retinoic acid-binding protein (CRABP1) in placental trophoblasts.."d PI: Patty Fan-Havard, Co-I: Douglas A. Kniss, Ph.D.
Sept. 1995
$19,554.00 from the Society of Infectious Diseases Pharmacists for study entitled, "Cytokine release with amphotericin B from Cryptococcus neoformans infected astrocytes."d
April 1995
$36,003.00 from American Association of Colleges of Pharmacy (AACP) for study entitled "A hospital based project for developing a continuity of pharmaceutical care discharge plan for patients with AIDS requiring home infusion therapy."d
July 1992
$10,000.00 from Centocor for evaluating the clinical trial entitled, "Centocor HA-1A efficacy in septic shock trial (CHESS Trial)."b
June 1992
$1,000.00 funding support from Amgen for the Postdoctoral Infectious Disease Fellowship program, Rutgers University, College of Pharmacy.a
April 1993
$25,538.00 from Bristol Myers Squibb for evaluating pharamcokinetic study entitled, "Open-label study of cefepime into the CSF of subjects with non-inflamed meningitis."b
Feb. 1993
$20,000.00 from Pfizer Pharmaceuticals for conducting the clinical trial entitled, "Randomized, placebo-controlled trial of E5 monoclonal antibody in patients with severe sepsis."b
April 1992
$400.00 funding from the Foundation of Pharmacists & Corporate America for AIDS for the protocol entitled, "The impact of Pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."c
March 1992
$85,000.00 from Janssen Research Foundation for evaluating the clinical trial entitled, "Double-blind, randomized, comparative study of itraconazole and fluconazole as maintenance therapy for preventing relapse of AIDS related cryptococcal meningitis."b
March 1992
$85,000.00 from Janssen Research Foundation for evaluating the clinical trial entitled, "Randomized, comparative study of Itraconazole and Fluconazole for the treatment of AIDS related Cryptococcal meningitis."b
Feb. 1992
$400.00 funding from the Foundation of Pharmacists & Corporate America for AIDS for the protocol entitled, "The impact of Pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."c
Dec. 1991
$100,000.00 grant from Bristol Myers Squibb for evaluating the clinical trial entitled, "An open-label multi-investigator comparative study of the safety and efficacy of cefepime and ceftizidime in the treatment of hospitalized patients with septicemia."b
March 1991
$2,000.00 Merck Education Grant for study entitled, "The impact of pharmacy education to high school students on the prevention of acquired immunodeficiency syndrome (AIDS)."b
Jan. 1991
$5,700.00 grant from Bristol Myers Squibb for evaluating the pharmacokinetics of cefepime in septicemic patients.a
Jan. 1991
$65,500.00 grant from Bristol Myers Squibb for clinical study entitled, "A study of cefepime in the treatment of serious bacterial infections particularly those caused by Staphylococci, Pseudomonas, and other less common gram-negative bacilli."a
July 1990
$31,000.00 grant from Abbott Laboratories for evaluating the efficacy and safety of temafloxacin vs. ceftazidime in the treatment of bacterial pneumonia in hospitalized patients.b
June 1990
$22,080.00 grant from Bristol Myers Squibb for determining the pharmacokinetics of cefepime in seriously-illed patients.a
Jan. 1990
$77,280.00 grant from Bristol Myers Squibb for a clinical study entitled, "A clinical study on the efficacy and safety of cefepime in the treatment of bacterial endocarditis including patients who are intravenous drug abusers."a
Dec. 1989
$2,000.00 awarded from Rutgers University Research Foundation for study protocol entitled, "A pharmacokinetic study on the brain tissue concentrations of antimicrobial agents in a rat model."a
"a" = Funds deposited at Rutgers University "b" = Funds deposited at the Veterans Biochemical Research Institute Department of Veterans Administration Medical Center, East Orange, NJ "c" = Funds deposited in the Academy of Students of Pharmacy (ASP) "d" = OSURF “e” = Southwest National Primate Research Center (SNPRC) “f” = University at Buffalo, The State University of New York
Latest Projects:
In her new position at the CHSU, Dr. Havard’s major academic responsibilities are to 1) establish and promote co-curricular activities and entrustable skills development for pharmacy students, and student scholarship mentoring programs; and, 2) coordinate the interprofessional education program and intercollaborative practice initiatives thru co-curricular activities at CHSU.
Her clinical research interests include 1) clinical efficacy and safety of curcumin in the treatment of aromatase-inhibitors-induced arthralgia in women with breast cancer; 2) characterization of drug-herb interactions of curcumin and anti-retroviral agents in HIV-infected patients; and, 3) student learning outcomes through co-curricular activities.
Peer-Reviewed Publications:
1)
Ho MJ, Chan E, Fan-Havard P, Thompson C, Hess JM. The Effects of Leadership Involvement and Part-time Employment on Pharmacy Student Academic Performance. Pharmacy Education 2014;14. (Access: http://pharmacyeducation.fip.edu/2014/05).
2)
Fan-Havard P, Zhongfa Liu, Monidarin Chou, Yonghua Ling, Aurélie Barrail-Tran, David W. Haas, Anne-Marie Taburet, and the ANRS12154 study group. "Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state" Antimicrob. Agents Chemother 2013; 57(5):2154-60. PMID: 23459477)
3)
Schmouder VM, Prescott GM, Franco A, Fan-Havard P. The Rebirth of Progesterone in the Prevention of Preterm Labor. Ann Pharmacotherapy 2013 47(4):527-36. (PMID:23535817)
4)
Chen W, Fan-Havard P, Yee LD, Cao Y, Stoner GD, Chan KK, Liu Z. A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2012;900:89-93. (PMID 22682887).
5)
Liu Z, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 2012, 69(3):679-89. (PMID 21968952)
6)
Chen R, Fan-Havard P, Schlabritz-Loutsevitch N, Chan KK, Liu Z. A Sensitive and Specific Liquid Chromatography/Tandem Mass Spectrometry Method for Quantification of Nevirapine and Its Five Metabolites and Their Pharmacokinetics in Baboons. Biomedical Chromatography 2010;24(7): 717-26 (PMID:19882749).
7)
Liu Z, Wu J, Xie Z, Liu S, Fan-Havard P, Huang TMC, Marcucci G, Chan KK. Quantification of Regional DNA Methylation by Liquid Chromatography/Tandem Mass Spectrometry. Analytical Biochemistry 2009;391(2):106-113.
8)
Joy SD, O’Shaughnessy R, Schlabritz-Loutsevitch N, Leland MM, Frost P, Fan-Havard P. Fetal Blood Sampling During the Second and Third Trimester in Baboons. J Med Primatol 2009;38(3):151-55.
9)
Liu Z, Fan-Havard P, Xie Z, Ren C, and Chan KK. A Liquid Chromatography/atmospheric Pressure Ionization Tandem Mass Spectrometry Quantitation Method for Nevirapine and Its Two Oxidative Metabolites, 2 Hydroxynevirapine and Nevirapine 4-Carboxylic Acid, and Pharmacokinetics in Baboons. Rapid Commun Mass Spectromet 2007;21:2734-42.
10)
Colombo DF, Lew JL, Pedersen CA, Johnson JR and Fan-Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus. Am J Obstet Gynecol; 2006;194:466-70.
11)
Fan-Havard P. Vision of Life: A lesson learned from a 98-year old artist on World AIDS Day. Ann Pharmacother 2005;39;2111-3.
12)
Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, and Fan-Havard P. Third trimester maternal toxicity with nevirapine use in pregnancy. Obstet & Gynecol 2005; 106:1032-1038.
13)
Hua Y, Fan-Havard P, Chan KK, and Liu Z. A subnanogram on-line column-switch LC/MS/MS quantitation method for nelfinavir and methoxy-phenol metabolite M1 in rat plasma. J Chromatograph B 2004;809:1-7.
14)
Knudtson E, Para M, Boswell H and Fan-Havard P. DRESS syndrome and renal toxicity with nevirapine-containing regimen in a pregnant patient with HIV. Obstet Gynecol 2003;101:1094-1097.
15)
Kniss DA, Sargent IL, Xie Y, Li Y, Kumar S, Linton E, Cohen P, Fan-Havard P, Redman CWG and Sargent IL. ED27 trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta 2002, vol 23(1):32-43.
16)
Johnson JR, Colombo DF, Gardner D, Cho E, Fan-Havard P and Shellhaas. Optimal penicillin dosing for Group B Streptococcus prophylaxis. Am J of Obst & Gyn 2001 185(4):850-3.
17)
Kendle JB and Fan-Havard P. Cidofovir in the treatment of Cytomegaloviral Disease. Ann Pharmacother 1998;32:1181-92.
18)
Fan-Havard P, Kucukarslan S, Legg J, Russell F, Laurila TL, Berger MJ, Green SK and Pathak D. Continuity of pharmaceutical services for patients with AIDS in the transition from hospital to home. Am J Health-Syst Pharm 1997;54:1407-12.
19)
Sharkey-Mathis PK, Graybill JR, Johnson ES, Hausrath SG, Pollard R, Mildvan D, Fan-Havard P, Eng RHK, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Silverman E and Gordon D. Amphotericin B lipid complex (ABLC) compared to amphotericin B in treatment of cryptococcal meningitis in AIDS patients. Clin Infect Dis 1996;22:315-321.
20)
Fan-Havard P, O'Donovan CA, Smith SM, Oh J, Bamberger MH and Eng RHK. Comparison of oral fluconazole with amphotericin B bladder irrigation for treatment of candidal cystitis. Clin Infect Dis 1995;21:960-5.
21)
O'Donovan CA, White ML, Cheung A, Fan-Havard P. A retrospective review of the incidence of seizures with imipenem therapy. Hosp Formulary 1995;30:172-5.
22)
Fan-Havard P, Sanchorowala V, Oh J, Moser E, Smith SP. Concurrent use of foscarnet and ciprofloxacin may increase the propensity for seizures. Ann Pharmacother 1994;28:869-72.
23)
O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RHK. Enteric eradication of Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105-9.
24)
Fan-Havard P, Koshy Z, Bais RM, Smith C, Eng RHK. A comparative pharmacokinetic study of teicoplanin in morphine pretreated, phenobarbital pretreated and control rats. J Antimicrob Chemother 1993;32:101-108.
25)
Fan-Havard P, Eng RHK, Frenia M, Smith SM, Akgun R, Pinto-Powell R. Peripheral leukocytosis and Clostridium difficile colitis. Turkish J Med Sci 1993;17:37-44.
26)
Eng RHK, Smith SM, Fan-Havard P, Ogbara TJ. The effect of antibiotics on the release of endotoxins. Diagn Microbiol Infect Dis 1993;16:185-189.
27)
Fan-Havard P, Yamaguchi E, Smith SM, Eng RHK. Diastolic hypertension in AIDS patients with Cryptococcal meningitis. Am J Med 1992;93:347-8.
28)
Fan-Havard P. Accredited Continuing Education for LV/PN :Pneumocystis carinii pneumonia in AIDS patients. J Practical Nursing 1992;June:52-62.
29)
Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RHK. Resistance development among Candida isolates from patients on prolonged antifungal therapy. Antimicrob Agents Chemother 1991;35:2302-2305.
30)
Eng RHK, Lynch AM, Smith SM, Ambros RA, Fan-Havard P, Mangia A, Tecson-Tumang F, Cherubin C. Imipenem resistance in a case of AIDS with relapsing Pseudomonas meningitis. South Med J 1990;83:979-980.
31)
Smith SM, Bais P, Eng RHK, Fan-Havard P, and Tecson-Tumang F. Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. J Antimicrob Chemotherapy 1990;26:567-72.
32)
Nahata MC, Fan-Havard P, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of intravenous rifampin in pediatric patients undergoing CSF shunt placement. Eur J Clin Pharmacol 1990;38:515:17.
33)
Fan-Havard P. Accredited Continuing Education: Pneumocystis carinii pneumonia in AIDS patients. Pharmacy Times 1990;56:108-21.
34)
Nahata MC, Fan-Havard P, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid CSF) concentrations of nafcillin in pediatric patients undergoing CSF shunt procedure. Chemotherapy 1990;36:98-102.
35)
Fan-Havard P, Nahata MC, Bartkowski H, Barson WJ, and Kosnik E. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy 1990;36:103-8.
36)
Smith SM, Eng RHK, Bais P, Fan-Havard P. Development of ciprofloxacin-resistant methicillin resistant Staphylococcus aureus during therapy. E. Lewin-Epistein Ltd., Jerusalem. 1989;672.1-672.
37)
Fan-Havard P, Nahata MC and Brady M. Ganciclovir: A review of pharmacology, therapeutic efficacy, and potential use for treatment of congenital cytomegalovirus infection in children. J Clin Pharm Therap 1989;14:329-40.
38)
Fan-Havard P, Nahata MC. A rapid analysis of nafcillin using high performance liquid chromatography. Therap Drug Monit 1989;11:105-8.
39)
Fan-Havard P, Nahata MC, Barson W, Bartkowski H, and Kosnik E. Histamine-like reaction following a single dose of intravenous rifampin. Clin Pharm 1988;7:616-20.
40)
Fan-Havard P, Nahata MC. Treatment and prevention of cerebrospinal fluid shunt infections. Clin Pharm 1987;6:866-80.
Book Chapters (peer-reviewed)
1)
Fan-Havard P and Lamberjack K. PSAP VII. Women’s and Men’s Health. Special Considerations for HIV in Women. In: Pharmacotherapy Self-Assessment Program VII. Book 6. 2010:pp 43-67. Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook A Patient-Focused Approach, 5th Edition. McGraw-Hill Company, Inc., New York, 2002: pp:345-347.
2)
Crutchley R, Brilliant A, Fan-Havard P, Morse G. Maraviroc. In: HIV Clinical Manual, 1st Edition. Eds Singh N, Shafer RW, and Swindells S. (Epub: Section II, Antiretroviral Therapy, Part B. Anitretroviral Agents. Access: Antimicrobe.edu). ESun Technologies, LLC., Pittsburg, PA.
3)
Fan-Havard P and Zabawski EJ. Cidofovir. In: Antimicrobial Therapy and Vaccines: Volume II: Antimicrobial Agents, 2nd Edition. Eds Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse G. ESun Technologies, LLC., Pittsburg, PA. 2005: pp:731-745.
4)
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook A Patient-Focused Approach, 6th Edition. McGraw-Hill, Company, Inc., New York, 2005: pp:352-354.
5)
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook: Instructor’s Guide, 5th edition. McGraw-Hill Company, Inc., 2002: Available on CD-ROM (ISBN: 0-07-140684-0).
Abstracts and Scientific Presentations (Selected 15 of 56 abstracts and scientific presentations):
1)
“Successful implementation of intercollaborative practice experience to prepare pharmacy students for the Advanced Practice Pharmacists Skills under SB 493.” Accepted to the 2016 CPhA West Coast Exchange Annual Meeting April 28-30th, 2016, San Francisco, CA.
2)
Hudspeth J, Ibrahim H, Phanthachack L, Tyner T, Trueblood PR, and Havard P. Intercollaborative Integration of Pharmacy Students to Improve Medication Reviews in Older Adults with Fall Risks. Accepted to the AACP and AFPC Annual Meeting in National Harbor, MD. July 11th -15th, 2015 National Harbor, Maryland.
3)
Ohtake PJ, Fish DR, Wietig PT,Lucke KT, Fan-Havard P, Antonson D, Ellis A, Elze D, Fiebelkorn K. What’s Good for the Goose is Good for the Gander: Using an Interprofessional Leadership Approach to Develop a University IPE Curriculum. Presented as a poster presentation at the Collaborating Across Borders (CAB) IV and Interprofessional Collaboration: Transformative Change from the Classroom to Practice, June 12th-14th, 2013, Vancouver, BC, Canada.
4)
Lucke KT, Ellis A, Fan-Havard P, Elze D, Ohtake PJ, Antonson D, K Fish DR, Fiebelkorn, and Wietig PT. From Classroom to Community: Building Social Accountability in Health Professions’ Education and Collaborative Practice. Presented as an oral presentation at the Collaborating Across Borders (CAB) IV and Interprofessional Collaboration: Transformative Change from the Classroom to Practice, June 12th-14th, 2013, Vancouver, BC, Canada.
5)
Fan-Havard P, Liu Z, Chou M, Ling Y, Barrail-Tran A, Haas D, Taburet AM, and ANRS 12154 Study group. “Different Nevirapine Metabolite Profiles with Single-dose and at Steady-state". [Abstract N112] Presented at the 2012 19th CROI meeting in Seattle Washington, USA. March 5-8, 2012.
6)
Drozdowicz M, Jaenecke K, Tong A, Franco A, Ramirez N, Barr T, Beyer W, Brazeau D, Fan-Havard P. Aperio ImageScope algorithm: a more sensitive tool in detecting differences in IHC staining intensity of the placental vasculature as compared with visual scoring by a clinical pathologist. Submitted to the 2011 ACCP Annual Meeting, Pittsburg PA Oct 16th – 19th, 2011.
7)
Tong, A, Franco A, Ramirez N, Barr TJ, Beyer W, Brazeau DA, Fan-Havard P. A Pilot Study to Quantitate Placental ß-Catenin Using Morphometric Analysis of Tissue Microarray Sections in Women with Gestational Diabetes, HIV, and Normal Healthy Pregnancies. [Abstract # 305]. Presented at the 2009 Annual Meeting of the American College of Clinical Pharmacy, October 18-21, 2009; Anaheim, CA 2009. Selected Best Student Poster Finalist.
8)
P Fan-Havard, Y Ling, RM Lubin, A Forrest, DW Haas, K Chan, Z Liu. Pharmacokinetics of Nevirapine and its Unglucuronidated Metabolites Following a Single Dose in Healthy African Americans Volunteers. [Abstract #3067 ] Presented at the 5th International AIDS Society July 19th-22nd, 2009 Cape Town, South Africa.
9)
Lubin RM, Tam PY, Brazeau D, Forrest A, Colombo D, Liu Z and Fan-Havard P. The Relationship of ABCB1 Gene Expression and the C3435T and G2677T Polymorphisms between Maternal and Fetal Peripheral Blood Mononuclear Cells (PBMCs) [Abstract 931]. Presented at the 2009 16th CROI meeting, Montreal Canada.
10)
Franco A, Joy S, Kang S, Poi M, Hunkler J, Brady M, Koletar S, Para M, and Fan-Havard P. Maternal and newborn outcomes in a multidisciplinary HIV Pregnancy Program”[Abstract 149] Presented at the 2005 Annual Meeting of the American College of Clinical Pharmacy, October 23-26, 2005, San Francisco, California.
11)
EJ Knudtson, LS Vasist, M Williams, MF Para, MT Brady, and P Fan-Havard. Maternal and Newborn Outcomes Following Implementation of a Multidisciplinary HIV-High Risk Pregnancy Clinic [Abstract no. 373]. Presented at the 2003 Society for Gynecologic Investigation Annual Scientific Meeting, March 27th – 30th, 2003.
12)
Fan-Havard P, Lieb CA, Monahan CM, Cho E, Wymer SK and Richard VB. Nelfinavir (NFV)-Induced Glucose Intolerance in Pregnancy: Placental and Fetal Outcomes in Rats. [Abstract No. 428]. Presentation at the 40th Annual Meeting of the Infectious Diseases of America, Chicago, IL. Oct. 24th-27th, 2002.
13)
Fan-Havard P, Park JL, Park CS and Kniss DA. Characterization of 17-b estradiol biosynthesis in first trimester human placental trophoblasts (ED27). Presented at the 46th Annual Meeting of the Society For Gynecologic Investigation, March 10th-13th, 1999, Atlanta, GA
14)
Al-Haddadon D, Fan-Havard P, Boghossian J, Morton R, Vincent D, Dungo L, Eng RHK, Johnson ES. Amphotericin B lipid complex (ABLC) in the treatment of cryptococcal meningitis in AIDS. [Abstract No. 002344] A World United Against AIDS. VIII International Conference on AIDS/III STD World Congress, Amsterdam, the Netherlands. July 19-24, 1992.
15)
Fan-Havard P, Oh J, O’Donovan CA, Smith SM, Eng RHK, Bamberger MH. Amphotericin B bladder irrigation (AmBBI) vs. Fluconazole (Flu) in the treatment of Candida cystitis. [Abstract No. 631] The 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, California. October 11-14, 1992.
Personal Information:Married to Donald B. Havard and with two beautiful boys, Andrew and Nick Havard. Enjoys golf, photography, “shooting the breeze” with students, and risks aversion when downhill skiing.
Academic Fellow & Post-Graduate Instructor of Clinical Sciences 559-701-2104 yhu@chsu.edu
Department: Clinical Sciences
Year Began at CHSU: 2018
Current Classes Taught:
PHR746 Patient Care III
Education:
PharmD, California Health Sciences University, Clovis, California
Master of Science, Zoology, Shaanxi Normal University, Xi’an, China
Bachelor of Science, Biology, Shaanxi Normal University, Xi’an, China
Doctor of Philosophy coursework and dissertation, Molecular Biology and Biochemistry, Chinese Academy of Agricultural Sciences, Beijing, China
Professional Affiliations:
American Society for Clinical Pharmacology & Therapeutics (ASCPT)
American Pharmacy Association (APhA)
American Society of Health System Pharmacists (ASHP)
California Pharmacy Association (CPhA)
California Society of Health System Pharmacists (CSHP)
Professional Service:
CHSU California Pharmacy Student Leadership (CAPSLEAD) member (2015-2016)
Experience:
Staff Research Associate, Department of Plant Sciences, University of California, Davis.
Conducted extensive genomic research focusing on genomic analyses, including construction of DNA physical mapping of animals and plants and the development of genomic resources for large genomic DNA.
Latest Projects & Publications (selected):
Hu Yuqin, Zhang Jie, Song Fuping, Shu Changlong, Huang Dafang, Construction of Stable Shuttle Expression Vectors pQMV and pGMP, Journal of Agricultural Biotechnology, 2004 Vol.12 No.2: 202-206.
Jiajie Wu, Yong Q. Gu, Yuqin Hu, Frank M. You, Abhaya M. Dandekar, Charles A. Leslie, Mallikarjuna Aradhya, Jan Dvorak, Ming-Cheng Luo, Characterizing the Walnut Genome Through Analyses of BAC End Sequences, Plant Molecular Biology, January 2012, Volume 78, Issue 1, pp 95–107. Principal Laboratory Researcher.
Yniv Palti, Carine Genet, Guangtu Gao, Yuqin Hu, Frank M. You, Mekki Boussaha, Caird E. Rexroad & Ming-Cheng Luo, A Second Generation Integrated Map of the Rainbow Trout (Oncorhynchus mykiss) Genome: Analysis of Conserved Synteny with Model Fish Genomes, November 2011, Marine Biotechnology 14(3): 343-57. Principal Laboratory Researcher.
Personal Information:
Yuqin is originally from Urumqi, China. Prior to coming to the United States, she lived in Xi’an, China, and Beijing, China. Yuqin has lived in Clovis with her husband Steven since 2014. Her hobbies including spending time with family, cooking, hiking, and travel.
Assistant Dean for Student Affairs and Enrollment Assistant Professor of Clinical Sciences 559-546-6049 jhughes@chsu.edu
Department: Clinical Sciences
Year Began at CHSU: 2017
Current Classes Taught:
• PHR 645: Patient Care II (topics include Benign Prostatic Hypertrophy, Urinary Incontinence, and Erectile Dysfunction)
Education:
• Washington State University, Doctor of Pharmacy
• Washington State University, Bachelor of Science in Psychology
Professional Affiliations:
• American Association of Colleges of Pharmacy (AACP)
• APhA (and WSPA, OSPA)
• ASHP (and OSHP)
Professional Service:
• Student Services SIG Chair-Elect, AACP
Experience:
• Assistant Dean for Student Affairs and Assistant Professor, Pacific University School of Pharmacy
• Director of Experiential Education and Assistant Professor, Pacific University School of Pharmacy
• Coordinator for Experiential Advancement and Assistant Professor, Pacific University School of Pharmacy
Latest Projects & Publications:
• Darbishire PL, Devine PS, Proctor AJ, Horner WJ, Hoffmann EM, Ott CA, Fuentes DG, Hughes JA. National Survey Exploring Drug Screening in Pharmacy Programs. Am J Pharm Educ. Posted online on Sept 29, 2017.
• Hughes JA, Cleven AJ, Ross J, Fuentes DG, Elbarbry F, Suzuki M, Della Paolera MA, Carter NS, Stamper BD, Low P, Malhotra A, Faro SJ. A Comprehensive Reflective Journal-Writing Framework for Students to See their Experiences through Diverse Lenses and Develop Actionable Goals. Am J Pharm Educ. Posted online on Sept 25, 2017.
• Hughes J, Della Paolera M, Stalvey K, Madu C, Rao D, Devaud L, Doyle I, Roberts S, Fuentes D. (2016). Mentorship at All Levels: A Culture of Mentorship in a Health-Professions Degree Program. In Dominguez, N. & Alexander, D. (Eds.), 9th Annual Mentoring Conference Proceedings: Developmental Networks: The Power of Mentoring and Coaching. University of New Mexico, Albuquerque, NM.
• Hughes J, Fuentes D, Gundersen D. Formalizing a Mentorship Program Between Graduate/Professional and Undergraduate Students to Increase Admissions, Retention, Professionalism, and Engagement. Pacific University Intercollegiate Collaborative Grant:, Forest Grove, OR
Personal Information:
• Dr. Hughes graduated with his PharmD from Washington State University in 2002, and has a background in independent and compounding pharmacies. Before pursuing a full-time career in academia, he served as a preceptor and Clinical Affiliate Faculty Member for Washington State University, Oregon State University, and Pacific University. He has also worked in a variety of settings including veterinary pharmacy, independent pharmacy, compounding pharmacy, chain pharmacy, and manufacturing.
Assistant Professor of Clinical Sciences 559-701-2109 ylafi@chsu.edu
Department: Clinical Sciences
Year Began at CHSU: 2018
Current Classes Taught:
PHR 746: Patient Care III
PHR 747: Patient Care IV
Education:
Doctor of Pharmacy
Campbell University College of Pharmacy and Health Sciences
Buies Creek, NC
Bachelor of Science in Pharmaceutical Sciences
Chemistry Minor
North Carolina Central University
Durham, NC
Professional Affiliations:
• Society of Infectious Diseases Pharmacists (SIDP)
• Infectious Diseases Society of America (IDSA)
• American College of Clinical Pharmacy (ACCP)
• Phi Lambda Sigma Pharmacy Leadership Society (PLS)
• Kappa Epsilon Pharmacy Fraternity (KE)
Professional Service:
TBD
Experience:
PGY2 Infectious Diseases Pharmacy Residency
BronxCare Health System, Bronx, NY
PGY1 Pharmacy Practice Residency
Virginia Hospital Center, Arlington, VA
Teaching and Learning Certificate
Shenandoah University School of Pharmacy, Winchester, VA
Clinical Pharmacist
Duke Children’s Hospital and Health Center, Durham, NC
Consultant Pharmacist
Pharmaceutical Product Development (PPD®), Morrisville, NC
Latest Projects & Publications:
Lafi Y, Cani E, Zeana C, Kang KS. Impact of Antimicrobial Stewardship on Fluoroquinolone Utilization in the Outpatient Setting at an Academic Medical Center. ASHP Midyear Clinical Meeting [Poster]. Orlando, Florida. December 2017.
Personal Information:
I am originally from Cary, NC and enjoy the outdoors, trying different cuisines, and reading any mystery novel by Agatha Christie (Queen of Crime). My current practice interests include antimicrobial stewardship, HIV, and resistance patterns of gram negative bacteria.
Assistant Dean for Education Director, Office of Teaching and Learning 559-374-2230 wofstad@chsu.edu
Biography
Department: • Clinical Sciences
Year Began at CHSU: • 2015
Current Classes Taught: • PHR 645 Patient Care II
Education: • Kaiser Permanente, Diablo Service Area, Walnut Creek, California, Pharmacy Practice Residency
• University of California, San Francisco (UCSF), San Francisco, California, Doctor of Pharmacy
• California Institute of Technology (Caltech), Pasadena, California, Bachelor of Science, Chemical Engineering
• Whitman College, Walla Walla, Washington, Bachelor of Arts, Chemistry
Professional Affiliations: • American Association of College of Pharmacy • Northern California College of Clinical Pharmacy • American College of Clinical Pharmacy • Team-Based Learning Collaborative • California Simulation Alliance
Professional Service: • Team-Based Learning Collaborative (TBLC), Consultant-Trainer Program, Co-facilitator • 15th Annual TBLC Meeting, Program Committee • California Interprofessional Education Research Academy, Cofounder • American College of Clinical Pharmacy (ACCP), Past-President Northern California Chapter • UC Davis Medical Center
Experience: • Certified Diabetes Educator (CDE) • TBL Consultant Trainer, certified by the Team-Based Learning Collaborative • APhA Pharmacist & Patient-Centered Diabetes Care • Board Certified Pharmacotherapy Specialist • Trainer of Immunization Administration certified by Drug Store News • Cardiopulmonary resuscitation (CPR) certified by the American Heart Association • Emergency Contraception certified by Pharmacy Access Partnership • Pharmacy-Based Immunization Delivery certified by ASHP • California Registered Pharmacist, License No. RPH 61775
Awards: • Ken Miller Award for Assessment of Educational Effectiveness, 2015 • Jeff King Pharmacy Leadership Award, Nominee, 2014 • Peer Award in Teaching, 2013 • Teacher of the Year, 2013 • Teacher of the Year, 2012 • Outstanding Community Service Award, 2011 • Grant Recognition Award, 2011 • Bowl of Hygeia Award, Nominee, 2008 • UC Regents Scholar, 2006-2008 • The Long Award for Excellence in Teaching, 2007 • The Long Award for Excellence in Teaching, 2006 • UCSF Dean’s Apple Teaching Award, 2006 • UCSF Dean’s Apple Teaching Award, 2005 • UCSF Frank M. Goyan Award, 2005
Latest Projects & Publications:
Integration of IPE into the Curriculum: ACPE Standard 11
The Evidence Behind High Performing Teams
Pathways to Expand the Effectiveness of Teaching and Learning: A workshop for educators to engage active learning strategies and explore team-based learning (TBL)
Exploring Team Contracts to Build Better Teams
Optimizing Team Building in TBL: Days 1 through 100
A Comparison between a Simulation-Based and Traditional Direct Patient Care Introductory Pharmacy Practice Experiences
A Bridge to Quality: The Pharmacist-Managed Primary Care Clinic
Development of a Team Contact for Team-Based Learning
The Impact of Grading Readiness in Team-Based Learning
Team-Based Learning in Pharmacy Education
Team-Based Learning: Windfalls and Pitfalls
Integrating Team-Based Learning and High-Fidelity Simulation for Interprofessional Education
Optimizing Student Engagement with Novel TBL Techniques that Get Students Moving
Incorporation of high fidelity simulation learning experiences within a didactic and experiential curriculum
A field guide for transforming your *yawn* clinical lectures into a lively team-based learning (TBL) classroom
Leadership and Quality (Student Body Council Retreat Workshop)
Continuous Formative Assessment of Team-Based Learning: RATs, BATs, and CATs
Comparing a Simulation Based Introductory Pharmacy Practice Experience (IPPE) to Traditional Direct Patient Care IPPEs
Pathways to Expand the Effectiveness of Teaching and Learning: A workshop for educators to engage active learning strategies and explore team-based learning (TBL)
Introduction to TBL Workshop
Team-Based Learning Primer Workshop
Faculty Orientation to Team-Based Learning
Focus on Quality (University Retreat Workshop)
New Student Orientation to Team-Based Learning
Personal Information: Born in Portland Oregon, Living in Clovis, Husband to Amy, Father to Apollo and Orion.
Come to me for ...
•
Faculty peer assessment of facilitation, course materials, examinations
•
Support in designing and implementing educational scholarship
•
Curriculum and assessment design and alignment with outcomes using backward design principles
•
End of semester student peer evaluation and team roles
•
All things TBL, IPE, and process education
•
TA and new faculty development
•
Help with alternative progression plans
Lorilee Perry, BSN, MSN, FNP, CNS
Assistant Professor of Clinical Sciences 559-701-2107 lperry@chsu.edu
Current Classes Taught: • PHR 523: Pharmacokinetics • PHR 542: Pharmacy Practice Lab • PHR 632: Pharmacology II • PHR 644: Patient Care I • PHR 645: Patient Care II
Education: • Master of Science in Clinical Research 2011-2014 Clinical and Translational Sciences Center University of New Mexico Albuquerque, New Mexico• Doctor of Pharmacy 2006-2010 University of New Mexico, College of Pharmacy Albuquerque, New Mexico
Professional Affiliations: • American Association of Colleges of Pharmacy (AACP) • American College of Clinical Pharmacy (ACCP) • American Society of Health-Systems Pharmacists (ASHP) • American College of Cardiology (ACC)
Experience: • Cardiovascular Pharmacotherapy Fellowship University of New Mexico, College of Pharmacy Albuquerque, NM
New Mexico Center for Advancement of Research, Engagement and Science on Health Disparities (NM CARES HD) – Fellowship University of New Mexico Health Sciences Center Albuquerque, NM
ASHP Accredited Pharmacy Practice Residency University of New Mexico Hospital Albuquerque, NM
Latest Projects & Publications: Sarangarm P, London MS, Snowden SS, Dilworth TJ, Koselke LR, Sanchez CO, et al. Impact of Pharmacist Discharge Medication Therapy Counseling and Disease State Education: Pharmacist Assisting at Routine Medical Discharge (Project PhARMD). American Journal of Medical Quality 2013;28:292-300.
Personal Information: I grew up in New Mexico and enjoy outdoor activities. During my free time I enjoy spending time with my wife and our cats.
I completed my PharmD in 2010 from the University of New Mexico, College of Pharmacy; a PGY-1 residency in 2011 from the University of New Mexico Health Sciences Center; and Cardiovascular Pharmacotherapy Fellowship in 2014 from the University of New Mexico, College of Pharmacy.
My practice interests include: preventative cardiology, heart failure, and acute coronary syndromes.
My research interests include: Effects of antiplatelet drugs, especially aspirin, in special population of patients (e.g., Diabetics, obesity), and health-related quality of life in patients with heart failure.
Assistant Professor of Clinical Sciences 559-573-8121 msolis@chsu.edu
Lianjie Xiong, PharmD, MS, BCCP, BCPS
Assistant Professor of Clinical Sciences 559-701-2103 lxiong@chsu.edu
Department:
Clinical Sciences
Year Began at CHSU:
2018
Current Classes Taught:
TBD
Education:
Doctor of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL
Master of Science in Pharmaceutics, The Ohio State University, Columbus, OH
Professional Affiliations:
American College of Clinical Pharmacy (ACCP)
American College of Cardiology (ACC)
Experience:
PGY1 Pharmacy Practice Resident, Palmetto Health Richland, Columbia, South Carolina
PGY2 Cardiology Pharmacy Resident, Vanderbilt University Medical Center, Nashville, Tennessee
Emergency Medicine Pharmacist, Greenville Memorial Medical Center, Greenville, South Carolina
Adult/Internal Medicine Clinical Pharmacist, Palmetto Health Richland, Columbia, South Carolina
Latest Projects & Publications:
Peer-Reviewed Publications:
Xiong L, Lu ZK, Quidley AM, Alford SB, Bookstaver PB. Evaluation of Renal Function Estimation Formulas Specific to Dynamic Renal Function for Drug Dosing in Critically Ill Patients. South Med J. 2018: 111(5): 299-306.
National Poster Presentations:
Xiong L, Tan X, Moretz J, Merritt T, Cox Z. Association of myalgia in heart failure patients receiving bumetanide continuous intravenous infusion. Poster presentation at the 2018 American College of Cardiology Meeting. Orlando, FL. March 2018.
Member, New Investigator Grant Award Committee, AAPS
•
Member, Graduate Student Awards Committee, AAPS
Experience: Academic:
•
Professor of Pharmaceutics, College of Pharmacy, California Health Sciences University, CA, November 2013 – present.
•
Director of Pharmaceutical Research, College of Pharmacy, California Health Sciences University, CA, February 16, 2015 – August 2015
•
Adjunct Professor, Department of Biology, California State University, Fresno, CA, July 2014 – present
•
Graduate Faculty, Texas A&M University-Kingsville, TX, July 2010 – October 2013
•
Graduate Faculty, Texas A&M Health Science Center, TX, January 2009 – October 2013
•
Visiting Faculty, Department of Pharmacy, North South University, Dhaka, Bangladesh, June 2008 – present
•
Associate Professor of Pharmaceutics, College of Pharmacy, Texas A&M Health Sciences Center, TX, June 2007 – October 2013
•
Graduate Faculty, University of Wyoming, WY, January 1995 – May 2007
•
Associate Professor of Pharmaceutics (Tenured), School of Pharmacy, College of Health Sciences, University of Wyoming, WY, July 1999 – May 2007
•
Assistant Professor of Pharmaceutics, School of Pharmacy, College of Health Sciences, University of Wyoming, WY, February 1993 – June 1999
•
Teaching Assistant, Faculty of Pharmacy, University of Alberta, Edmonton, Canada, 1989 – 1992
•
Lecturer, Faculty of Pharmacy, University of Dhaka, Bangladesh, October 1984 – December 1988
Industrial
•
Scientist, Atrix Laboratories, Inc. Fort Collins, CO. July 2000 – March 2003
•
Visiting Scientist, Division of Drug Metabolism and Pharmacokinetics, SynPhar Laboratories Inc., Edmonton, Alberta, Canada July – August, 1994
•
Quality control officer, Unique Pharmaceuticals, Bangladesh, April – September, 1984
Latest Projects & Publications:
Development of self-nanoemulsifying drug delivery systems (SNEDDS) for enhancement of solubility and oral bioavailability of fenofibrate, a poorly water soluble drug. Mohsin, R. Alamri, A. Ahmad, M. Raish, F. K. Alanazi and M. D. Hussain. Submitted to International Journal of Nanomedicine, 2016.
Strategies for Developing Oral Vaccines for Human Papillomavirus induced cancers using nano/micro-particle mediated delivery system. M. N. Uddin, S. A. Kouziand D. Hussain. Journal of Pharmacy and Pharmaceutical Sciences, 2015, 18(2):220-34. PMID:26158287
Safety and Toxicity of Nanoparticles in Medicine. D. Hussain and M. Ogbuehi.TOXICOLOGY: The Past, Present, and Future of Basic, Clinical and Forensic Medicine 2015, Volume 1: 45-67, eds. Sethi R, Kolli C, Hussain D. Nova Science Publishers, Inc. New York.
Co-editor, TOXICOLOGY: The Past, Present, and Future of Basic, Clinical and Forensic Medicine 2015, Volume 1 and Volume 2, eds. Sethi R, Kolli C, Hussain D. Nova Science Publishers, Inc. New York.
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics and stability. T. A. Ahmed, H. M. Ibrahim, A. M. Samy, A. Kaseem, M. T. Nutan, D. Hussain. AAPS PharmSci Tec 2014, 15(3):772-80, PMID: 24648158.
Development of meloxicam in-situ implant formulation by Quality by Design Principle. M. Ibrahim, T. A. Ahmed, M. D. Hussain, Z. Rahman, A. M. Samya, A. A. Kassema, M. T. H. Nutan.Drug Development and Industrial Pharmacy 2014, 40(1): 66-73,PMID: 23298324.
Microglia, neuroinflammation and Aβ in Alzheimer’s disease. Zhiyou Cai,D. Hussain, Liang Jun Yan. International Journal of Neuroscience 2014. 124(5):307-21. PMID: 23930978.
Zirconium Phosphate Nanoplatelets: A Biocompatible Nanomaterial for Drug Delivery to Cancer. Saxena, A.Diaz, A. Clearfield, J. D. Batteas, and M. D. Hussain. Nanoscale 2013, 5:2328-2336. PMID: 23392208 (Designated as “hot article” by the journal).
Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. Saxena and M. D. Hussain. Journal of Biomedical Nanotechnology2013, 9: 1146-1154.PMID: 23909128.
Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastomamultiforme. V. Saxena and D. Hussain. Colloids and Surfaces B: Biointerfaces2013, 112: 350–355. PMID: 24012704.
Developing nano-particle based oral vaccine for cervical cancer. M. N. Uddin and D. Hussain. Proceedings of 1st AABPS Convention, 21-22, 2013. http://www.aabps.edu/Events.html
Pathways to USFDA approved product-505(b)(2). D. K. Chowdhury and D. Hussain. Proceedings of 1st AABPS Convention, 25-26, 2013. http://www.aabps.edu/Events.html
Folate Receptor Targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) Loaded Polymeric Nanoparticles for Breast Cancer. V Saxena, Y. Naguib and D. Hussain. Colloids and Surfaces B: Biointerfaces. 2012, 94: 274-80. PMID: 22377218.
Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and resistant cancer. V. Saxena and D. Hussain. International Journal of Nanomedicine. 2012,7:713–721. PMID: 22359450.
Zirconium phosphate nanoplatelets: a novel platform for drug delivery in cancer therapy. A. Díaz,V. Saxena, J. González, A. David, B. Casañas, J. D. Batteas, J. L. Colón, A. Clearfield, and D. Hussain. Chemical Communications2012; 48 (12):1754–6. PMID: 22218458.
Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance. Delwar Hussain, V. Saxena, J. F. Brausch, R. M. Talukder. International Journal of Pharmaceutics 2012; 422(1-2):290-4. PMID: 22101290.
Development of Biodegradable Injectable In Situ Implant and Microparticle Formulations for Sustained Delivery of Haloperidol. T. A. Ahmed, H. M. Ibrahim, F. Ibrahim, A. M. Samy, A. Kaseem, M. T. Nutan, M. D. Hussain. Journal of Pharmaceutical Sciences 2012,101 (10), 3753-3762. PMID:22753324.
Personal Information:
•
Hobbies- Hiking, Biking, World Geography, Soccer, Cricket, Ice Hockey.
Come to me for ...
•
Issues with teaching, research, community engagement, practice and service
•
Interpersonal conflicts
•
Workload and life balance
•
Faculty mentorship and development in all areas of teaching, scholarship, and service
•
Faculty development as clinicians and scientists, as well as career development support
•
Inter-departmental collaborations
•
Inclusion in CHSU culture
•
Liaison between departments and CAC
•
Support and resources at the department level
•
One on your mentors as a member of the department
•
Ways that we can contribute to advancing our disciplines, both internally and externally
•
Budget and purchase requests
•
Departmental mentoring and initiatives in research and scholarship
•
Opportunities for and constraints with engagement in professional, institutional, and/or community service
•
Feedback on and support for performance relative to areas of faculty responsibility that are evaluated annually and for promotion
•
Areas related to faculty workload efforts
Taher Hegab, PharmD, PhD (Medicinal Chemistry)
Assistant Adjunct Professor of Pharmaceutical and Biomedical Sciences 559-325-3600 thegab@chsu.edu
Farid Khalafalla, PhD (Biochemistry)
Assistant Professor of Pharmaceutical and Biomedical Sciences
Ph.D. in Biochemistry University of Missouri-Columbia, United States
•
B.Sc. in Pharmaceutical Sciences Faculty of Pharmacy, Cairo University, Egypt
Professional Affiliations:
•
American Hearth Association (AHA) - Member
•
International Society for Hearth Research (ISHR) - Member
Professional Service:
•
PLos One Journal - Reviewer
•
CHSU Admission Committee - Member
•
CHSU Curriculum Committee - Member
Experience:
Academic Experience
•
07/2018 – Present Assistant Professor of Pharmaceutical & Biomedical Sciences College of Pharmacy, California Health Sciences University, CA, US
•
09/2014 – 06/2018 Postdoctoral Fellow Mark Sussman Lab, San Diego State University, CA, US
•
08/2009 - 05/2014 Graduate Research Assistant Gary Weisman Lab, University of Missouri-Columbia, MO, US
•
01/2011 - 05/2011 Graduate Teaching Assistant BIOCHM 4272/7272, University of Missouri-Columbia, MO, US
Pharmaceutical Industry Experience
•
01/2009 - 06/2009 Medical Representative Sandoz/Novartis, Cairo, Egypt
Mentoring Experience
•
09/2014 - 06/2018 Undergraduate Student Team Management & Mentoring San Diego State University, CA, US
Latest Projects & Publications
Original Research, Review, and Editorial Articles
•
Cardiac progenitor cell ion currents: Revealing a little more on the lesser known – (J Physiol. 2018 Apr 20; doi: 10.1113/JP276132) Khalafallah FG, Sussman MA
•
Mechanisms of cardiac repair and regeneration – (Circ Res. 2018 Apr 13;122(8):1151-1163. doi: 10.1161/CIRCRESAHA.117.312586) Broughton KM*, Wang BJ*, Firouzi F, Khalafallah FG, Dimmeler S, Fernandez-Aviles F, Sussman MA ¬– [*equal contribution]
•
Cardiac c-Kit biology revealed by inducible transgenesis – (Circ Res. 2018 Apr 10; doi: 10.1161/CIRCRESAHA.117.311828) Gude NA*, Firouzi F*, Broughton KM, Ilves K, Nguyen KP, Payne CR, Sacchi V, Monsanto MM, Casillas AR, Khalafallah FG, Alvarez R, Dembitsky WP, Bailey BA, van Berlo J, Sussman MA ¬– [*equal contribution]
•
P2Y2 nucleotide receptor prompts human cardiac progenitor cell activation by modulating Hippo signaling – (Circ Res. 2017 Nov 10; 121(11):1224-1236. doi: 10.1161/CIRCRESAHA.117.310812.) Khalafalla FG, Greene S, Khan H, Ilves K, Monsanto M, Alvarez R Jr., Chavarria M, Nguyen J, Norman B, Dembitsky WP, Sussman MA
•
Empowering human cardiac progenitor cells by P2Y14 nucleotide receptor overexpression – (J Physiol. 2017 Oct 5; pp 1–14. doi: 10.1113/JP274980) Khalafalla FG, Kayani W, Kassab A, Ilves K, Monsanto MM, Alvarez R Jr., Chavarria M, Norman B, Dembitsky WP, Sussman MA
•
Inflammation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: Fighting against multiple opponents – (Cancer Growth Metastasis. 2017 May 15;10:1179064417709287. doi: 10.1177/1179064417709287) Khalafalla FG, Khan M
•
Concurrent isolation of three distinct cardiac stem cell populations from a single human heart biopsy – (Circ Res. 2017 Apr 26. 121(2):113-124. doi: 10.1161/CIRCRESAHA.116.310494) Monsanto MM, White K, Kim T, Wang BJ, Fisher K, Ilves K, Khalafalla FG, Casillas AR, Broughton KM, Mohsin S, Dembitsky W, Sussman MA
•
S100A4 protects the myocardium against ischemic stress – (J Mol Cell Cardiol. 2016 Oct 6;100:54-63. doi: 10.1016/j.yjmcc.2016.10.001) Doroudgar S, Quijada P, Konstandin M, Ilves K, Broughton K, Khalafalla FG, Casillas A, Nguyen K, Gude N, Toko H, Ornelas L, Thuerauf DJ, Glembotski CC, Sussman MA, Völkers M
•
Cardiac stem cell hybrids enhance myocardial repair – (Circ Res. 2015 Sep 25;117(8):695-706. doi: 10.1161/CIRCRESAHA.115.306838) Quijada P, Salunga H, Hariharan N, Cubillo J, El-Sayed FG, Moshref M, Bala K, Emathinger J, De La Torre A, Ormachea L, Alvarez R Jr., Gude N, Sussman MA
•
Increased expression of TGF-β signaling components in a mouse model of fibrosis induced by submandibular gland duct ligation – (PLoS One. 2015 May;10(5):e0123641. doi: 10.1371/journal.pone.0123641.) Woods L, Camden J, El-Sayed FG, Khalafalla MG, Petris M, Erb L, Weisman GA
•
P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells – (Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C83-96. doi: 10.1152/ajpcell.00380.2013.) El-Sayed FG, Camden J, Woods L, Khalafalla MG, Petris M, Erb L, Weisman G
•
Loss of P2Y2 nucleotide receptor enhances early pathology in the TgCRND8 mouse model of Alzheimer’s disease – (Mol Neurobiol. 2014 Apr;49(2):1031-42. doi: 10.1007/s12035-013-8577-5.) Ajit D, Woods L, Camden J, Thebeau C, El-Sayed FG, Greeson G, Erb L, Petris M, Miller D, Sun G, Weisman G
Published Research Abstracts
•
P2Y14 Nucleotide Receptor Overexpression: Towards Enhanced Stress Detection and Repair Responses in Human Cardiac Progenitor Cells – (Circulation 2017 Nov 11; 136 (Suppl 1), A16991-A16991) Khalafalla FG, Kayani W, Kassab A, Ilves K, Alvarez R Jr., Chavarria M, Norman B, Sussman MA
•
P2Y14 Nucleotide Receptor Overexpression: Letting Blind Cardiac Progenitor Cells ‘See’ Again – (Journal of Molecular and Cellular Cardiology 2017 Nov 1; 112, 139) Khalafalla FG, Kayani W, Kassab A, Ilves K, Alvarez R Jr., Chavarria M, Norman B, Sussman MA
•
P2Y14 Nucleotide Receptor Overexpression: Letting Blind Cardiac Progenitor Cells ‘See’ Again – (Circulation Research 2017 Jul 21; 121 (Suppl 1), A25-A25) Khalafalla FG, Kayani W, Kassab A, Ilves K, Alvarez R Jr., Chavarria M, Norman B, Sussman MA
•
P2Y2 Nucleotide Receptor Overexpression: Letting Blind Cardiac Progenitor Cells ‘See’ Again – (Circulation 2016 Nov 11; 134 (Suppl 1), A18660-A18660) Khalafalla FG, Greene S, Nguyen J, Khan H, Sussman MA
•
P2Y2 Nucleotide Receptor Overexpression: Letting Blind Cardiac Progenitor Cells ‘See’ Again – (Circulation Research 2016 Jul 22; 119 (Suppl 1), A353-A353) Khalafalla FG, Greene S, Nguyen J, Ilves K, Norman B, Alvarez R Jr., Sussman MA
•
Empowering Cardiac Progenitor Cell-Mediated Repair of Injured Myocardium by Overexpressing P2Y14 Nucleotide Receptor – (Circulation 2015 Nov 10; 132 (Suppl 3), A15173-A15173) El-Sayed FG, Nguyen J, Sussman MA
•
Empowering Cardiac Progenitor Cell-Mediated Repair of Injured Myocardium by Overexpressing P2Y2 Nucleotide Receptor¬ – (Circulation Research 2015 Jul 17; 117 (Suppl 1), A159-A159) El-Sayed FG, Mark Sussman MA
Personal Information:
Seminar Presentations in National/International Meetings and Academic Institutions
•
International Society for Heart Research–North American Section 37th Meeting; Halifax, Nova Scotia, Canada – (June 2018)
•
Cardiovascular Center of Excellence, Louisiana State University; New Orleans, LA – (February 2018)
•
American Heart Association: Scientific Sessions; Anaheim, CA – (November 2017)
•
Division of Cardiology, School of Medicine, University of Louisville; Louisville, KY – (October 2017)
•
International Society for Heart Research–North American Section 35th Meeting; Seattle, WA – (June 2015)
•
Gordon Research Conference: Salivary Glands and Exocrine Biology; Galveston, TX – (February 2013)
Awards
•
Early Career Investigator Travel Award, International Society for Heart Research–North American Section 37th Meeting – (June 2018)
•
Early Career Investigator Travel Award, International Society for Heart Research–North American Section 36th Meeting – (May 2017)
•
Travel Grant, International Society for Heart Research–World Congress 22nd Meeting – (April 2016)
•
International Poster Award, International Society for Heart Research–North American Section 35th Meeting – (June 2015)
•
Travel Award, University of Missouri–Columbia, Department of Biochemistry – (April 2013)
•
Professional Presentation Travel Scholarship, University of Missouri–Columbia, Graduate School – (April 2013)
•
Travel Award, University of Missouri–Columbia, Department of Biochemistry – (February 2013)
•
Travel Award, Salivary Glands and Exocrine Biology Gordon Research Conference – (February 2013)
Hobbies
•
I enjoy playing soccer and travelling with family and friends.
Luo H, Shenoy AK, Li X, Jin Y, Jin L, Cai Q, Tang M, Liu Y, Chen H, Reisman D, Wu L, Seto E, Qiu Yi, Dou Y, Casero Jr RA, Lu J. MOF acetylates the histone demethylase LSD1 to suppress epithelial-tomesenchymal transition. Cell Reports. 2016; 15(12): 2665-78
Jin Y, Cai Q, Shenoy AK, Lim S, Zhang Y, Charles S, Tarrash M, Fu X, Kamarajugadda S, Trevino JG, Tan M, Lu J. Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation. Oncotarget. 2016; doi: 10.18632/oncotarget.7159. [Epub ahead of print]
Jin Y, Shenoy AK, Doernberg S, Chen H, Luo H, Shen H, Lin T, Tarrash M, Cai Q, Hu X, Fiske R, Chen T, Wu L, Mohammed KA, Rottiers V, Lee SS, Lu J. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development. Cancer Letters. 2015; 362 (1): 70-82
Shenoy AK, Lu J. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. Cancer Lett. 2014. pii: S0304- 3835(14)00630-2. doi: 10.1016/j.canlet.2014.10.031
Tang M, Shen H, Jin Y, Lin T, Cai Q, Pinard MA, Biswas S, Tran Q, Li G, Shenoy AK, Tongdee E, Lin S, Gu Y, Law BK, Zhou L, Mckenna R, Wu L, Lu J. The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition. J Biol Chem. 2013; 288(38): 27680-27691
Shenoy AK, Butterworth E, Huang EH. ALDH as a marker for enriching tumorigenic human colonic stem cells. Methods Mol Biol. 2012; 916: 373- 385
Shenoy AK, Fisher RC, Butterworth EA, Pi L, Chang L, Appelman HD, Chang M, Scott EW, Huang EH. Colitis-to-Cancer Transition: High WntActivity Confers Sustained Tumor-Initiating Potential on Human Precursor-Colon Cancer Stem Cells. Cancer Research, 2012; 72(19): 5091-5100
Pi L, Shenoy AK, Liu J, Kim S, Nelson N, Hauswirth WW, Petersen BE, GS, Scott EW. CCN2/CTGF regulates neovessel formation via binding structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB, 2012; 26(8): 3365-3379
Pi L, Xia H, Liu J, Shenoy AK, Hauswirth WW, Scott EW. Role of connective tissue growth factor in the retinal vasculature during development and ischemia. Invest Ophthalmol Vis Sci. 2011; 52(12): 8701-8710
Madlambayan G.J, Butler J. M, Hosaka K, Jorgensen M, Fu D, Guthrie S. M, Shenoy AK, Brank A, Russell K. J, Otero J, Siemann D. W, Scott E. W, Cogle C. R. Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood, 2009; 114(19): 4310-4319
August 2016 – Present Assistant Professor of Pharmacology Department of Pharmaceutical and Biomedical Sciences California Health Sciences University, College of Pharmacy, Clovis, California
•
August 2012 – July 2016 Assistant Research Scientist Department of Pharmacodynamics College of Pharmacy University of Florida, Gainesville, Florida
•
January 2010 – July 2012 Postdoctoral Fellow Department of Physiology and Functional Genomics College of Medicine University of Florida, Gainesville, Florida
Pharmaceutical Industry:
•
May 2003 – April 2005 Scientific Officer Department of Pharmacology Nicholas Piramal Research Center, Goregaon, Mumbai, India
•
July 2002- March 2003 Intern Department of Pharmacology Torrent Research Center, Gandhinagar, Gujarat, India
Latest Projects & Publications:
1.
Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Nair A, Francis J, Unger T, Raizada MK, Steckelings UM, Sumners C, Katovich MJ. Selective activation of AT2 receptor attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol. 2015; 172(9):2219-31.
2.
Santisteban MM, Ahmari N, Marulanda Carvajal J, Zingler MB, Qi Y, Kim S, Joseph J, Garcia-Pereira F, Johnson RD, Shenoy V, Raizada MK, Zubcevic J. Involvement of Bone Marrow Cells and Neuroinflammation in Hypertension. Circ Res. 2015; 117(2):178-91
3.
Qi YF, Zhang J, Wang L, Shenoy V, Krause E, Oh SP, Pepine CJ, Katovich MJ, Raizada MK. Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. J Mol Med (Berl) 2016; 94(1):37-49.
4.
De Maria ML, Araújo LD, Fraga-Silva RA, Pereira LA, Ribeiro HJ, Menezes GB, Shenoy V, Raizada MK, Ferreira AJ. Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. Protein Pept Lett. 2016; 23(1):9-16.
5.
Rathinasabapathy A, Bruce E, Espejo A, Horowitz A, Sudhan DR, Nair A, Guzzo D, Francis J, Raizada MK, Shenoy V, Katovich MJ. Therapeutic potential of adipose stem cells derived conditioned medium against pulmonary hypertension and lung fibrosis. Br J Pharmacol. 2016 [Epub ahead of print]
Ph.D., (Neuropsychopharmacology), Panjab University, Chandigarh, India
Professional Affiliations:
•
International Brain Research Organization
•
Indian Pharmacological Society
•
Indian Academy of Neurosciences
•
Inflammation Research Association (USA)
Professional Service:
Editorial Board Member: • EC Pharmacology and ToxicologyJournal Reviewer: • Journal of Pharmacology and Experimental Therapeutics • Brain Research • Psychopharmacology • Indian Journal of Pharmacology • Journal of Medicinal Food • Pharmacology, Biochemistry, Behavior • Pharmacological Reports
Experience: Academic:
•
2015 - Present Assistant Professor of Pharmacology California Health Sciences University, Clovis, CA, USA
•
2008 - 2015 Visiting Faculty Swamy Ramananda Tirtha Institute of Pharmaceutical Sciences, Nalgonda, India
•
2002 - 2005 Assistant Professor, Pharmacology University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
•
1997 - 1998 Associate Lecturer Nalanda College of Pharmacy, Nalgonda, AP, India
Pharmaceutical Industry
•
2008-2015 Senior Lead Investigator Neuroscience Biology, Disease Sciences and Technology, Biocon-Bristol Meyers Squibb R&D center, Bangalore, India
Latest Projects & Publications:
• Original Research Articles - 65 • Reviews and Book Chapters - 5 • Research Abstracts - 60Kumar KV, Ruda A, Sreedhara MV, Subramani TS, Prasad DS, Das MA, Li YW, Bristow LJ, Naidu PS, Vikradidhyan RK. Bacillus Calmette-Guerin (BCG) Vaccine induced a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice. Brain, Behavior and Immunity, 2014; 42: 204-211.Fowler CJ, Björklund E, Lichtman AH, Naidu PS, Congiu C, Onnis V. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoidanandamide. J Enzyme Inhib Med Chem. 2013; 28(1):172-82.Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. PharmacolBiochemBehav. 2011 Oct;99(4):718-25Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Sallwey DE, ImadDamaj M, Lichtman AH. The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology. 2011 Feb-Mar;60(2-3):244-51
University College of Pharmaceutical Sciences Kakatiya University Warangal, India 1993-2004, B.Pharmacy, M.Pharmacy and Ph.D.
Post-Doctoral Fellowship:
•
College of Pharmacy and Health Sciences Mercer University Atlanta, Georgia May 2004-April 2008
Academic Appointments:
•
August 15, 2013 – Present Associate Professor of Pharmaceutics, California Health Sciences University, Fresno, California.
•
April 15, 2008 – August 13, 2013 Assistant Professor of Pharmaceutics, California Northstate University College of Pharmacy, Rancho Cordova, California
Editorial Boards:
•
2011-Present Journal of Pharmaceutical Education and Research
•
2011-Present International Journal of Pharmacy
Presentations:
1.
Chandra Sekhar Kolli and Ajay K Banga. Maltose microneedles for transdermal delivery. 3rd Pharmaceutical Sciences World Congress, April 2007, Amsterdam, The Netherlands.
2.
Chandra Sekhar Kolli and Ajay K Banga. Assessment of barrier perturbation caused by maltose microneedles. 34th Annual meeting and exposition of the Controlled Release Society, July 2007, Long beach, CA.
3.
Chandra Sekhar Kolli Haripriya Kalluri, Nishil Desai and Ajay Banga. DermaRollerTM as an alternative means to breach the stratum corneum barrier. 7th Annual Georgia Life Sciences Summit, October, 2007, Atlanta, GA.
4.
Chandra Sekhar Kolli, Haripriya Kalluri, David Farquhar and Ajay Banga. Effect of occlusion and formulation pH on pore closure in vivo following microneedle pretreatment. 7th Annual Georgia Life Sciences Summit, October, 2007, Atlanta, GA.
5.
Chandra Sekhar Kolli and Ajay K Banga. Transdermal delivery using soluble microneedles. 33rd Annual meeting and exposition of the Controlled Release Society, July 2006, Vienna, Austria.
6.
Chandra Sekhar Kolli and Ajay K Banga. Soluble microneedles for the transdermal delivery of nicardipine hydrochloride. The AAPS Journal. Vol. 8, No. S2, Abstract M1168 (2006).
7.
Chandra Sekhar Kolli and Ajay K Banga. Transdermal delivery using soluble microneedles. 26th Graduate Research Association of Students in Pharmacy, June 2006, Northeastern University, Boston, MA.
8.
K. Chandra Sekhar and Y Madhusudan Rao. Formulation and evaluation of bioadhesive buccal tablets of chlorpheniramine maleate. Proceedings of 53rd Indian Pharmaceutical Congress, December 2001, New Delhi, India.
9.
Chandra Sekhar Kolli and Ajay K Banga. Ethanol as co-solvent in transdermal iontophoretic delivery of nicardipine hydrochloride. Nanomedicine and Drug Delivery Symposium, October 2006, Omaha, NE.
10.
Chandra Sekhar Kolli, Jyotsna Paturi and Ajay K Banga. Biophysical characterization of the skin after insertion of microneedles or microdialysis probe 2006 US Symposium for Biophysics and Skin imaging, October 2006, Atlanta, GA.
11.
Chandra Sekhar Kolli and Ajay K Banga. Transdermal Iontophoretic Delivery of Nicardipine Hydrochloride. Proceedings of 57th Indian Pharmaceutical Congress, December 2003, Hyderabad, India.
12.
Chandra Sekhar Kolli, Madhusudan Rao Yamasani, Naidu KVS, Vamshi Yamasani, Kishan Veerabrahma. Design and evaluation of buccal patches of chlorpheniramine maleate. The AAPS Journal Vol. 7, No. S2, Abstract W5087 (2005).
13.
Chandra Sekhar Kolli, Naidu KVS, Vamshi Y, Kishan V and Madhusudan Rao Y. Design and evaluation of buccal patches of nitredipine. 32nd Annual meeting and exposition of the controlled release society, July 2005, Miami, FL.
14.
Satya Lanke, Chandra Sekhar Kolli, Guohua Li, J G Strom, Ajay K Banga. Transdermal delivery of low molecular weight heparin using combination of microneedles and iontophoresis The AAPS Journal Vol. 9, No. S2, Abstract T3176 (2007).
15.
S.S.S Lanke, C.S. Kolli, J.G Strom and A. K. Banga. An investigation of LMWH interaction with stratum corneum and its effect on transdermal permeation. 7th Annual Georgia Life Sciences Summit, October, 2007, Atlanta, GA.
16.
Prasuna Anguru, Chandra Sekhar Kolli and Madhusudan Rao Yamsani., Animal models for in vitro absorption studies using carbamazepine, 7th Annual Georgia Life Sciences Summit, October 2007, Atlanta, GA.
17.
Jyotsna Paturi, Chandra Sekhar Kolli, Phil Friden and Ajay Banga. Iontophoretic delivery of tetracycline hydrochloride across hairless rat skin. The AAPS Journal Vol. 8, No. S2, Abstract M1149 (2006).
18.
Jyotsna Paturi, Chandra Sekhar Kolli, Phil Friden and Ajay Banga. Iontophoretic delivery of tetracycline hydrochloride across hairless rat skin. 6th Annual Georgia Life Sciences Summit, October, 2006, Atlanta, GA.
19.
Satya Lanke, Chandra Sekhar Kolli, Guohua Li, J G Strom, Ajay K Banga. Transdermal delivery of low molecular weight heparin using combination of microneedles and iontophoresis. 27th Graduate Research Association of Students in Pharmacy, June 2007, Newark, NJ, USA.
20.
Prasuna Anguru, Chandra Sekhar Kolli and Madhusudan Rao Yamsani., Role of P- glycoprotein efflux on in vitro intestinal transport of carbamazepine. Proceedings of 59th Indian Pharmaceutical Congress, December 2007, Varanasi, INDIA.
21.
Prasuna Anguru and Chandra Sekhar Kolli., Genotoxic impurities in pharmaceutical formulations – A regulatory perspective. Proceedings of 61st Indian Pharmaceutical Congress, December 2009, Ahmedabad, INDIA.
22.
Rajesh V, Chandra Sekhar K and Madhusudan Rao Y. Formulation and evaluation of mucoadhesive drug delivery systems. Proceedings of 54th Indian Pharmaceutical Congress, December 2002, Pune, India.
23.
A.A Dixit, K. Chandra Sekhar and Y Madhusudan Rao. Effect of diltiazem on the pharmacokinetics of domperidone. Proceedings of 51st Indian Pharmaceutical Congress, December 1999, Baroda, India.
24.
Sonal Saluja, Jyotsna Paturi, Chandra Sekhar Kolli, Advait Badkar, Sandeep Nema and Ajay Banga. Stability of Triptorelin During Transdermal Transport The AAPS Journal Vol. 9, No. S2, Abstract T3187 (2007).
25.
G Jayasagar, M. Krishnakumar, K. Chandra Sekhar and Y Madhusudan Rao. Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers. Proceedings of 53rd Indian Pharmaceutical Congress, December 2001, New Delhi, India.
26.
Gaurav Tolia, Alan Smith, Heather Janssen, Chandra Sekhar Kolli, Ajay Banga, and Frank Tagliaferri. Polymer matrix for transdermal delivery of a highly water-soluble drug, hydromorphone hydrochloride, through microporated skin of the hairless rat: In vivo pharmacokinetics The AAPS Journal Vol. 8, No. S2, Abstract M1184 (2006).
27.
Gaurav Tolia, Alan Smith, Heather Janssen, Chandra Sekhar Kolli, Ajay Banga, and Frank Tagliaferri. Transdermal delivery of hydromorphone hydrochloride in the rat using the PassPort™ system. 6th Annual Georgia Life Sciences Summit, October, 2006, Atlanta, GA.
28.
M. Pavan Kumar, Y Madhusudan Rao, T Ashok and K Chandra Sekhar. Career scenario for pharmaceutics specialization – An analysis. Proceedings of 55th Indian Pharmaceutical Congress, December 2003, Chennai, India.
29.
CS Kolli, H. Kalluri , D. Farquhar, AK Banga. Characterization of micropores and factors affecting their closure In Vivo. The AAPS Journal Vol. 10, No. S2, Abstract 1659 (2008).
30.
SS Lanke, C. Kolli, JG Strom, AK Banga. Microneedle mediated transdermal delivery of Low Molecular Weight Heparin. The AAPS Journal Vol. 10, No. S2, Abstract 2291 (2008).
31.
P. Anguru, C. Kolli, M. Yamsani. Influence of P-glycoprotein efflux on the In vitro intestinal transport of carbamazepine. The AAPS Journal Vol. 10, No. S2, Abstract 3010 (2008).
32.
Desai, CS Kolli, AV Badkar, S. Nema, AK Banga. Microneedle mediated transdermal delivery of human Growth Hormone. The AAPS Journal Vol. 10, No. S2, Abstract 1362 (2008).
33.
Chandra Sekhar K, Vishnu Y, Kishan VB and Madhusudan Rao Y., Transbuccal delivery of nitrendipine from a bioadhesive buccal patch” Proceedings of 60th Indian Pharmaceutical Congress, December 2008, New Delhi, INDIA.
34.
Satya Lanke, Chandra Sekhar Kolli, Guohua Li, J G Strom, Ajay K Banga. Transdermal delivery of low molecular weight heparin using combination of microneedles and iontophoresis. The AAPS Journal Vol. 9, No. S2, Abstract T3176 (2007).
35.
X. Jin, C. S. Kolli, D. L. Parsons, R. Babu. Microneedle Assisted Iontophoretic Transdermal Delivery of Prochlorperazine. The AAPS Journal Vol. 11, No. S2, Abstract W4105 (2010).
36.
Pawar K, Kolli C, Babu R.J. Stability and degradation profiles of Lys-Pro-Val (KPV) peptide in aqueous solutions. Poster presentation at the 2011 AAPS Annual Meeting and Exposition; October 23–27, 2011; Washington, D.C. Poster T2164.
37.
Pawar K. R, Kolli C, Babu R.J. Effect of Lipophilicity of Drugs on the Iontophoretic Delivery across Microneedle Treated Human Skin. Poster presentation at the 2012 AAPS Annual Meeting and Exposition; October 14–18, 2012; Chicago, IL. Poster R6329.
38.
Indiran Pather and Chandra Sekhar Kolli. Novel Method to Encourage Peer Teaching Amongest Students. Poster presentation at the 11th Annual Team-Based Learning Conference; March 1-3, 2012 in St. Petersburg, FL.
Publications:
1.
Pawar, K. R., Smith, F., Kolli, C. S. and Babu, R. J. (2013), Effect of Lipophilicity on Microneedle-Mediated Iontophoretic Transdermal Delivery Across Human Skin In Vitro. J. Pharm. Sci.. doi: 10.1002/jps.23694.
2.
Kolli CS, Chadha G, Xiao J, Parsons DL, Babu RJ. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro. J Drug Target. 2010; 18(9): 657-664.
3.
Chandra Sekhar Kolli and Ajay K. Banga. Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery. Pharmaceutical Research 2008; 25(1):104-13.
4.
Kalluri H, Kolli CS, Banga AK Characterization of microchannels created by metal microneedles: formation and closure. AAPS Journal 2011; 13(3):473-81.
5.
Lanke SS, Kolli CS, Strom JG, Banga AK. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. Int J Pharm. 2009; 5;365(1-2):26-33.
6.
Li G, Badkar A, Nema S, Kolli CS, Banga AK. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm. 2009; 23;368(1-2):109-15.
7.
Chandra Sekhar K, Ramesh G, Vamshi Vishnu Y, Naidu, KVS, Kishan V and Madhusudan Rao Y. Design and evaluation of bioadhesive buccal patches of chlorpheniramine maleate. Drug Delivery. 2008; 15:195–201.
8.
Chandra Sekhar K, Ramesh G, Vamshi Vishnu Y, Kishan V and Madhusudan Rao Y. Development of Mucoadhesive Patches for Buccal Administration of Prochlorperazine: Evaluation of In Vitro Release and Mechanical Properties. International Journal of Pharmaceutical Sciences and Nanotechnology 2008; 1(1):64-70.
9.
Madhusudan Rao Y, Chandra Sekhar K, Vamshi Vishnu Y, Ramesh Gannu and Naidu KVS. Novel buccoadhesive formulation of chorpheniramine maleate, in vitro and in vivo characterization. Asian Journal of Pharmaceutics. 2007; 1(1): 33-40.
10.
Vishnu YV, Chandra Sekhar K, Ramesh G, Rao YM. Development of mucoadhesive patches for buccal administration of carvedilol. Current Drug Delivery. 2007; 4(1): 27-39.
11.
Yamsani VV, Gannu R, Kolli C, Rao ME, Yamsani MR. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharmaceutica. 2007; 57(2): 185-97.
12.
Jayasagar. G, Krishna Kumar. M, Chandra Sekhar. K, and Madhusudan Rao Y. Effect of cephalalexin on the pharmacokinetics of metformin in healthy human volunteers. Drug Metabolism and Drug Interactions. 2002; 19 (1): 41-48.
13.
Jayasagar. G, Krishna Kumar. M, Chandra Sekhar. K, and Madhusudan Rao Y. Validated HPLC determination of celecoxib in serum samples and its application to clinical pharmacokinetic study. Pharmazie. 2002; 57(9): 619-621.
14.
M. Krishna Kumar, G. Jayasagar, K. Chandra Sekhar, T. Ashok, Y. Madhusudan Rao. Validated HPLC method for the determination of ranitidine in human serum and its application in a clinical pharmacokinetic study. Pharmazie. 2003; 58: 284-285.
15.
G. Jayasagar, M. Krishna Kumar, K. Chandra Sekhar, V. Rajesh and Y. Madhusudan Rao. Effect of itraconazole on the pharmacokinetics of celecoxib in healthy human volunteers. Pharmazie. 2003; 58: 840-841.
16.
G. Jayasagar, M. Krishna Kumar, K. Chandra Sekhar, and Y.Madhusudan Rao. Influence of rifampicin pretreatment on the pharmacokinetics of celecoxib in healthy male volunteers. Drug Metabolism and Drug Interactions 2003, 19(4) 287-295.
Research Contracts (Funded):
Title:
Development of a subcutaneous formulation for ETI 381 & ETI 382
Source:
Epiomed Therapeutic Inc
Amount:
$65,000.00
With:
Indiran Pather, DPharm (Principal Investigator)
Status:
Completed
Special Honors/Awards:
•
Publication of the Year Award, California Northstate University College of Pharmacy, April 2010
•
Walgreens Diversity Award, California Northstate University College of Pharmacy, April 2010
•
Walgreens Diversity Award, California Northstate University College of Pharmacy, April 2011
•
Young Postdoc travel award, Pharmaceutical Sciences World Congress, Amsterdam, April 2007
•
Young Investigator scholarship, International Society for Biophysics and Imaging of Skin, Atlanta, GA, October 2006
•
Senior Research Fellowship (Engineering & Technology), University Grants Commission, Government of India, 2000 – 2004
•
Suresh Kare Indoco Foundation Award, Indoco Remedies Limited, India, 2000
•
Junior Research Fellowship, University Grants Commission, India 1998 – 1999
•
University Gold Medal, Kakatiya University India, 1997
•
State Merit Scholarship – Board of Secondary Education, India, 1993
Scientific and Professional Societies:
•
Member, American Association of Pharmaceutical Scientists, 2004 – Present
•
Member, American Association of Colleges of Pharmacy, 2004 - Present
Yuwei Wang, MS (Medicinal Chemistry), PhD (Pharmaceutics)
Assistant Professor of Pharmaceutics 559.374.2849 yuwang@chsu.edu
Department:
•
PBS
Year Began at CHSU:
•
2018
Current Classes Taught:
•
PHR514 Calculation
•
PHR540 Compounding
Education:
•
PhD-Pharmaceutics - University of Utah
•
MS-Medicinal Chemistry - Peking University
•
BS-Pharmacy - Peking University
Professional Affiliations:
•
AAPS
•
TBLC
Professional Service:
•
Seven years Pharmaceutical industry experience both in small bio-tech and international pharmaceutical companies where she worked extensively in drug formulation development and CMC regulatory affairs.
Latest Projects & Publications:
Wang Y, Grainger DW. Barriers to advancing nanotechnology to better improve and translate
nanomedicines. Frontiers of Chemical Science and Engineering. (2014) 8(3): 265-75
Wang Y, Liu J, Zhang J, et al. A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs. Int. J. Med. Sci. (2014)11(5): 479-487
Wang Y, Grainger DW, Developing siRNA therapies to address osteoporosis. Ther. Deliv. (2013)4(10):
1239-46
Wang Y, Tran KK, Shen H, Grainger DW. Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials. Biomaterials (2012)33(33):8540-7
Yang D, Liu X, Jiang X, Liu Y, Ying W, Wang H, Bai H, Taylor WD, Wang Y, et al. Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy. J. Control Release (2012)161(1): 124-131
Wang Y, Grainger DW. RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev (2012)64(12):1341-57
Wang Y, Panasiuk A, Grainger DW. Small Interfering RNA Knocks Down the Molecular Target of Alendronate, Farnesyl Pyrophosphate Synthase, in Osteoclast and Osteoblast Cultures. Mol. Pharmaceutics (2011)8(4): 1016-24
Takahashi H,* Wang Y,* Grainger DW. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. J. Control Release (2010)147(3):400-407. *co-first authors
Wang Y, Grainger DW. siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption. Pharm Res (2010)27(7):1273-84.
Wang Y, Cui G, Zhao M, Jian Y, et al. Bioassay-directed purification of an acidic phospholipase A2 from Agkistrodon halys pallas venom. Toxicon (2008)51:1131-1139.
Ph.D., Molecular Biology University of Southern California/City of Hope National Medical Center Los Angeles, California
•
B.S. Biological Sciences University of Southern California Los Angeles, California
Professional Affiliations:
• American Society for Microbiology • American Associate for the Advancement of Science • Pan-American Society for Virology • Society for Molecular Pathology
Professional Service:
• Technical Supervisor, Molecular Pathology and Microbiology Laboratories, Valley Children’s Hospital, Madera, CA
• Member, Biotechnology Advisory Board, Professional Science Master’s Degree Program. Departments of Biology and Chemistry, California State University, Fresno.
• Medical Counsel member, Gerson Lehrman Group, Inc. 850 3rd Ave Fl 9, New York, NY 10022
Experience:
Academic:
•
1999-present Valley Children’s Hospital, Madera, CA Supervisor, Molecular Pathology and Microbiology Laboratories
•
1990-1999 University of Miami School of Medicine, Miami, FL Associate Professor and Director of Research Department of Surgery, Division of Transplantation
•
1987-1990 University of Rochester, Rochester, NY Post-doctoral Fellow, Department of Biology.
•
1982-1986 Beckman Research Institute of the City of Hope, Duarte, CA. Graduate Student and Research Assistant
Latest Projects & Publications:
1.
Prospective Study for Clinical Validation of the Molecular-Based GenePOC Strep A, C/G assay for the Detection and identification of Group A β-hemolytic Streptococcus (Streptococcus pyogenes) and pyogenic Group C and G β-hemolytic Streptococcus (Streptococcus dysgalactiae subsp. equisimilis) nucleic acids from throat swab samples obtained from patients with signs and symptoms of pharyngitis. GenePOC, Inc., Quebec, Canada
2.
Detection of IgG and IgM antibodies for Coccidioides immitis/posadasii in pediatric patients symptomatic for San Joaquin Valley Fever using a rapid lateral-flow ELISA assay. IMMY, Corp., Norman, OK
3.
A-PACT: The Use of Inhaled Aztreonam to Eliminate or Decrease the Bacterial Burden of Pseudomonas Aeruginosa in Children with a Tracheostomy Tube. Gilead Sciences, Foster City, CA
Publications:
Books and Monographs:
1.
R.Cirocco, K.Zucker, M.Markou, V.Esquenazi, and J.Miller, PCR reverse dot blot oligotyping, in: DNA Typing Manual, South-Eastern Organ Procurement Foundation, Richmond, VA, 1994.
2.
L Fuller, K.Zucker, D.Asthana, S.Zhen, M.Carreno, V.Esquenazi, and J.Miller, The role of canine IFN-gamma in graft rejection evaluated in the canine transplant model, in: Cytokines in Veterinary Medicine, Horzinek and Schijns (eds.), CAB International, Wallingford, UK, 1996.
3.
C.Ciancio, G.Burke, D.Roth,K.Zucker, V.Esquenazi, A.Rosen, and J.Miller, Tacrolimus and mycophenolate mofetil as primary immunosuppression for renal allograft recipients, in: Kidney Transplant Rejection, Diagnosis and Treatment, L.Racusen, K.Solez, and J.Burdick (eds), Marcel Dekker, Inc., New York, 1998.
Referred Journal Articles:
1.
K.Zucker, A.Riggs, and S.Smith, Purification of human DNA(cytosine-5-)-methyltransferase, J.Cell.Biochem. 29 (1985), 337-349.
2.
A.DePoali-Roach, P.Roach, K.Zucker, and S.Smith, Selective phosphorylation of human DNA methyltransferase by protein kinase C, FEBS Lett. 197 (1986), 149-153.
3.
R.Pastori, K.Zucker, and Y.Xing, Restoration of binding of oxidized transcription factor IIIA to 5S RNA by thioredoxin, Nucleic Acids Res. 16 (1988), 8497-8507.
4.
D.Tremethick, K.Zucker, and A.Worcel, The transcription complex of the 5S RNA gene, but not transcription factor IIIA alone, prevents nucleosomal repression of transcription, J.Biol.Chem. 265 (1990), 5014-5023.
5.
K.Zucker, and A.Worcel, The histone H3/H4 complex supplemented with histone H2A-H2B dimers and DNA topoisomerase I forms nucleosomes on circular DNA under physiological conditions, J.Biol.Chem 265 (1990), 14487-14496.
6.
P.Lu, K.Zucker, V.Esquenazi, and J.Miller, Correlation of RFLP typing and MLC reactivity in dogs, Tissue Antigens 37 (1991), 224-229.
7.
J.Miller, V.Esquenazi, L.Fuller, K.Zucker, J.Fernandez, G.Burke, and J.Nery, The immunologic response to allografts: acute rejection, Clin. Transplant. 5 (1991), 477-488.
8.
K.Zucker, P.Lu, V.Esquenazi, and J.Miller, Cloning of the cDNA for canine interferon-gamma, J.Interferon Sci. 12 (1992), 191-194.
9.
M.Carreno, L.Fuller, K.Zucker, W-C.Yang, G.Burke, J.Nery, C.Gomez, V.Esquenazi, and J.Miller, Cross species reactivity of the anti-idiotype anti-OKT3 cascade between mouse and man, Human Immunol. 33 (1992), 249-258.
10.
K.Zucker, P.Lu, D.Asthana, M.Carreno, W-C.Yang, V.Esquenazi, L.Fuller, and J.Miller, Production and characterization of recombinant canine interferon-gamma, J.Interferon Sci. 13 (1993), 91-97.
11.
D.Asthana, W-C.Yang, K.Zucker, P.Lu, L.Fuller, V.Esquenazi, M.Carreno, D.Roth, G.Burke, J.Nery, and J.Miller, Effect of canine IFN-gamma and anti-IFN gamma on mixed lymphocyte kidney and islet cell co-cultures, Transplant Immunol. 1 (1993), 282-293.
12.
J.Fernandez, D.Asthana, K.Zucker, P.Lu, L.Fuller, W-C.Yang, V. Esquenazi, M.Carreno, D.Roth, G.Burke, J.Nery, and J.Miller, Mixed lymphocyte kidney and islet cell cocultures: The effect of IFN- and anti-IFN-. Transplantation Proc. 25 (1993), 117-119.
13.
R.Koutouby, C.Zucker, K.Zucker, G.Burke, J.Nery, D.Roth, V.Esquenazi, and J.Miller, Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients using a quantitative polymerase chain reaction, Human Immunol. 36 (1993), 227-234.
14.
L.Fuller, M.Carreno, V.Esquenazi, K.Zucker, S.Zheng, D.Roth, G.Burke, J.Nery, L.Olson, and J.Miller, Characterization of anti-canine cytokine monoclonal antibodies specific for IFN-gamma. Effect of anti-IFN-gamma on renal transplant rejection, Tissue Antigens 43 (1994), 163-169.
15.
K.Zucker, P.Lu, L.Fuller, D.Asthana, V.Esquenazi, and J.Miller, Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E.coli, Lymphokine and Cytokine Res. 13 (1994), 191-196.
16.
D.Roth, K.Zucker, R.Cirroco, A.DeMattos, G.Burke, J.Nery, V.Esquenazi, S.Babischkin and J.Miller, The impact of hepatitis C virus infection on renal allograft recipients, Kidney Int. 45 (1994), 238-244.
17.
K.Zucker, R.Cirroco, D.Roth, L.Olson, G.Burke, J.Nery, V.Esquenazi, and J.Miller, Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation, Transplantation 57 (1994), 832-840.
18.
J.Nery, D.Weppler, R.Cirocco, K.Zucker, J.Casella, W.Faria, M.Carreno, M.Markou, S.Babischkin, M.Hill, S.LaRue, V.Esquenazi, C.Gomez, H.Gharagozloo, R.Reddy, T.Parker, L.Jeffers, J.Smith, M.Allouch, G.Burke, E.Schiff, and J.Miller, Hepatitis C in liver transplantation: preliminary study of prognostic factors, Transplant Internat. (Suppl)(1994), S229-S231.
19.
K.Zucker, R.Cirocco, D.Roth, G.Burke, J.Nery, V.Esquenazi, and J.Miller, Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation, Transplant. Proc. 27 (1995), 943-944.
20.
D.Roth, R.Cirocco, K.Zucker, P.Ruiz, A.Viciana, G.Burke, M.Carreno, V.Esquenazi, and J.Miller, De novo membranoproliferative glomerulonephritis in hepatitis C virus infected renal allograft recipients, Transplantation 59 (1995), 1676-1682.
21.
D.Roth, K.Zucker, R.Cirocco, G.Burke, L.Olson, V.Esquenazi, and J.Miller, Transmission of HCV by kidney transplantation: Impact of perfusion techniques and course of viremia post transplant. Pediatric Nephrol. 9 (1995), S29-S34.
22.
E.Whitley, A.Bird, K.Zucker, and L.Wolfe, Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines, Anticancer Res. 15 (1995), 923-929.
23.
J.Nery, J.Casella, S.Tucci, P.Ruiz, W.Faria, L.Olson, J.Szust, D.Weppler, K.Zucker, A.Tzakis, and J.Miller, Early predictors of rejection in small bowel transplantation: The role of tissue messenger RNA coding for cytokines, Surg. Forum 46 (1995), 441-444.
24.
P.Lu, K.Zucker, L.Fuller, V.Esquenazi, A.Tzakis, and J.Miller, Cloning and expression of canine interleukin-10, J. Interferon and Cytokine Res. (1996), 1103-1109.
25.
C.Zucker, K.Zucker, M.Carreno, D.Asthana, V.Esquenazi, and J.Miller, Longitudinal monitoring of IL-2 mRNA in renal transplant patients and in unmodified canine renal transplants, Human Immunol.45 (1996), 1-12.
26.
R.Garcia-Morales, V.Esquenazi, K.Zucker, C.I.Gomez, L.Fuller, M.Carreno, R.Cirocco, A.Alamo, T.Karatzas, G.Burke, G.Ciancio, D.Temple, H.Fernandez, C.Ricordi, A.Tzakis, and J.Miller, Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-Flow), Transplantation 62 (1996), 1-12.
27.
G.Ciancio, G.Burke, D.Roth, K.Zucker, A.Tzakis, and J.Miller, The significance of infections in donor organs. J. Transplantation & Immunology: Letter 12 (1996), 12-14.
28.
K.Zucker, D.Roth, R.Cirocco, R.Mathews, L.Fuller, T.Karatzas, Y.Jin, G.Burke, J.Nery, M.Webb, A.Tzakis, V.Esquenazi, and J.Miller, Transplant associated autoimmune mechanisms in human hepatitis C virus infection, J. Clin. Immunol. 16 (1996), 60-70.
29.
D.Roth, K.Zucker, R.Cirocco, G.Burke, G.Ciancio, V.Esquenazi, and J.Miller, A prospective study of hepatitis C virus infection in renal allograft recipients, Transplantation 61(1996), 886-889.
30.
Y.Jin, L.Fuller, M.Carreno, K.Zucker, V.Esquenazi, T.Karatzas, A.Tzakis, J.Miller, A possible role of HCV-induced liver infiltrating lymphocytes immune reactivity in hepatocellular damage. J. Clin. Immunol. 17 (1997), 140-153.
31.
R.Cirocco, G.Fragulidis, D.Weppler, K.Zucker, M.Markou, X.Zervos, A.Viciana, V.Esquenazi, J.Nery, K.Reddy, E.Schiff, J.Miller, and A.Tzakis, Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers, Transplant. Proc. 29 (1997), 2839-2840.
32.
K.Zucker, V.Esquenazi, A.Rosen, A.Tsaroucha, L.de Faria, D.Roth, G.Burke, G.Ciancio, A.Tzakis,and J.Miller, MMF Pharmacokinetics in renal transplant patients recieving Prograf and Cellcept in combination therapy. Transplant Proc.29 (1997), 334-336.
33.
A.Glavik, M.Goldberg, A.Tsaroucha, M.Webb, R.Khan, D.Weppler, J.Nery, M.Khan, K.Zucker, A.Viciana, J.Miller, and A.Tzakis, Mycophenolate Mofetil rescue therapy in liver transplant recipients, Transplant Proc. 29 (1997), 549-552.
34.
K.Zucker, V.Esquenazi, A.Rosen, A.Tsaroucha, D.Roth, G.Burke, G.Ciancio, A.Tzakis, J.Miller, Unexpected augmentation of MMF pharmacokinetics in renal transplant patients recieving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.Transplant. Immunol. 5 (1997), 225-232.
35.
Cirocco, R., Zucker, K., Contreras, N., Olson, L., Cravero, J., Markou,M. Babischkin, S., Fernandez, E., Burke, G., Esquenazi, V., Tzakis, A., and Miller, J. The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody positive donors and clinical follow up. Transplantation 63 (1997), 1702-3.
36.
M.Carreno, C.Gomez, H.Gharagozloo, R.Cirocco, K.Zucker, R.Garcia-Morales, L.Fuller, V.Esquenazi, A.Tzakis, and J.Miller, Assessment of homozygosity in HLA-class I antigens and their distribution/quantitation in subpopulations of cells by flow cytometry. Transplant Proc. 29 (1997), 1426-1429.
37.
R.Garcia-Morales, K.Zucker, V.Esquenazi, R.Cirocco, M.Carreno, T.Karatzas, L.Fuller, G.Burke, H.Fernandez, D.Temple, G.Ciancio, D.Roth, A.Rosen, C.Ricordi, A.Tzakis, and J.Miller, Detection of chimeric bone marrow-derived cell subsets by the PCR-Flow assay after cadaveric kidney transplant (CKTx) and donor bone marrow (DBM) infusion. Transplant Proc. 29 (1997), 1219-1221.
38.
R.Garcia-Morales, M.Carreno, J.Mathew, K.Zucker, R.Cirocco, G.Ciancio, G.Burke, D.Roth, D.Temple, A.Rosen, L.Fuller, V.Esquenazi, T.Karatzas, C.Ricordi, A.Tzakis, J.Miller, The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J. Clin. Invest. 99 (1997), 1118-1129.
39.
Garcia, R., Carreno, M., Mathew, J., Zucker, K., Ciancio, G., Burke, G., Rosen, A., Fuller, L., Esquenazi, V., Karatzas, T., Ricordi, C., Tzakis, A., and Miller, J. Follow-up of the in vitro and in vivo effects of chimeric cells of donor bone marrow lineage as detected by PCR-Flow assays in kidney transplant recipients. Transplantation Proc. 29 (1997), 1219-21.
40.
Garcia, R., Esquenazi, V., Carreno, M., Karatzas, T., Gomez, C., Cirocco, R., Zucker, K., Fuller, L., Alamo D., Temple, H., Fernandez, G., Ciancio, G., Burke, G., Webb, M., Nery, J., Roth, D., Ricordi, C., Tzakis, A., and Miller, J. PCR-Flow analysis used to detect the levels of chimerism in peripheral blood of bone marrow infused organ allograft recipients at the time of rejection episodes. Transplantation Proc. 29 (1997), 2179-80.
41.
P.Ruiz, L.Hao, K.Zucker, N.Zacharievich, A.Viciana, M.Shenkin, and J.Miller, Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status, Transplant Immunol. 5 (1997), 152-161.
42.
R.Garcia-Morales, M.Carreno, J.Mathew, K.Zucker, G.Cianco, G.Burke, D.Roth, D.Temple, L.Fuller, V.Esquenazi, L.Eskind, N.Kenyon, C.Ricordi, A.Tzakis, and J.Miller, Continuing observations on the regulatory effects of donor specific bone marrow infusions and chimerism in kidney transplant recipients, Transplantation 65 (1998), 956-965.
43.
J.Mathew, M.Carreno, K.Zucker, L.Fuller, C.Ricordi, A.Tzakis, V.Esquenazi, and J.Miller, Cellular immune response of human bone marrow cells and their suseptability to commonly used immunosuppressive drugs in transplantation, Transplantation 65 (1998), 947-955.
44.
K.Zucker, A.Tsaroucha, L.deFaria, V.Esquenazi, J.Miller, and A.Tzakis, Prevalence of hepatitis G virus in liver transplant patients as assessed by the polymerase chain reaction, Organ & Tissue Transplantation 2 (1998), 13-17.
45.
K.Zucker, A.Tsaroucha, L.Olson, V.Esquenazi, A.Tzakis, and J.Miller, Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation, Ther. Drug Monit. 21 (1999), 35-43.
46.
J.Miller, J.Mathew, R.Garcia-Morales, K.Zucker, M.Carreno, Y.Jin, L.Fuller, G.Burke, G.Ciancio, A.Tzakis, C.Ricordi, L.Olson, A.Rosen, D.Roth, and V.Esquenazi, The human bone marrow as an immunoregulatory organ, Transplantation 68 (1999), 1079 - 1090.
47.
A.Tsaroucha, K.Zucker, V.Esquenazi, L.deFaria. J.Miller, and A.Tzakis, Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and CellCept combination therapy, Transplant. Int. 8 (2000), 143 - 146.
48.
K. Zucker, P. Kamberi, D. Stevens, K. Clemmons, R. Sobel, G. Cloud, P. Williams, and S. Lieb. Temporal expression of immunological mediating molecules in the brain basilar artery and cerebrospinal fluid of rabbits with coccicioidal meningitis/vasculitis. Clin. Exp. Immunol. 143 (2006), 458-466.
Healthcare Information and Management Systems Society
Professional Service:
Research Co-chair with the Pharmacy Quality Alliance Academic Affairs Committee
Experience:
2011-2016 Assistant Professor, College of Pharmacy Texas A&M Health Science Center
Awards:
2016 Rufus A. Lyman Award – American Association of Colleges of Pharmacy
2013 New Investigator Award – American Association of Colleges of Pharmacy
Latest Projects & Publications:
Measuring the value of pharmacist clinical services that improve health outcomes and reduce medical expenses.
Teaching innovation and commercializing promising ideas from faculty, staff and students.
Personal Information:
Grew up in the large metropolitan area called Los Angeles and now enjoy the Central Valley where I can spend time with my wife and daughter.
Come to me for ...
•
Issues with teaching, research, community engagement, practice and service
•
Interpersonal conflicts
•
Workload and life balance
•
Faculty mentorship and development in all areas of teaching, scholarship, and service
•
Faculty development as clinicians and scientists, as well as career development support
•
Inter-departmental collaborations
•
Inclusion in CHSU culture
•
Liaison between departments and CAC
•
Support and resources at the department level
•
One on your mentors as a member of the department
•
Ways that we can contribute to advancing our disciplines, both internally and externally
•
Budget and purchase requests
•
Departmental mentoring and initiatives in research and scholarship
•
Opportunities for and constraints with engagement in professional, institutional, and/or community service
•
Feedback on and support for performance relative to areas of faculty responsibility that are evaluated annually and for promotion
•
Areas related to faculty workload efforts
Wendy Duncan, PhD (Pharmaceutics)
Senior Vice President for Academic Affairs and Provost Dean, College of Pharmacy Professor of Social and Economic Sciences 559-325-3600 wduncan@chsu.edu
Wendy Duncan, PhD, is a distinguished expert in new program evaluation and development and curriculum design and assessment. With extensive experience in strategic planning and change management, she is a visionary with a passion for developing innovative learning and scholarly opportunities for students. Prior to joining CHSU, Dr. Duncan served as Dean in the College of Pharmacy and Health Sciences and Professor at Drake University in Des Moines, Iowa and as Vice President of Academic Affairs, Dean of Pharmacy, and Professor at St. Louis College of Pharmacy. Prior to her appointment as Dean, she served as a faculty member at the University of Toronto and as Associate Dean for Education and Director of the Office of Teaching, Learning and Assessment at Auburn University’s Harrison School of Pharmacy. Duncan received her Bachelor of Science in Pharmacy and PhD in Pharmaceutics from the University of Toronto.
At both St. Louis College of Pharmacy and Auburn University Harrison School of Pharmacy, Duncan instituted curricular transformation with the extensive use of team-based and problem-based learning and a greater focus on practice management, advocacy and community service. Duncan has demonstrated her comprehensive understanding of accreditation procedures through the successful completion of self-studies resulting in accreditation and reaccreditation at four institutions at both the programmatic and regional level and by serving as a site evaluator for the American Council for Pharmaceutical Education since 2007. Duncan also conveys a strong focus on intra- and inter-professional coalitions and research and she formally instituted the Des Moines Area Interprofessional Collaborative among five colleges and universities. She was instrumental in amassing the Missouri Pharmacy Coalition, a consortium of colleges, state pharmacy organizations and board members creating a legislation- and policy-focused alliance. She was responsible for developing inter-professional alliances with Saint Louis University, Washington University School of Medicine, and Goldfarb School of Nursing providing new educational, practice, and research opportunities for students and faculty.
Adjunct Assistant Professor of Social and Economic Sciences 559-325-3600 cly@chsu.edu
McKenna Salazar
Director of Academic Affairs Instructor of Social and Economic Sciences 559-374-2478 msalazar@chsu.edu
Negin Tahvildary, PhD
Adjunct Assistant Professor of Social and Economic Sciences 559-325-3600 ntahvildary@chsu.edu
Anne VanGarsse, MD, FAAP, CHCEF, CPE
Associate Dean for Clinical Affairs, Community Engagement and Population Health, College of Osteopathic Medicine Associate Professor of Social and Economic Sciences, College of Pharmacy 559-701-2121 559-712-4143 avangarsse@chsu.edu
Dr Anne VanGarsse serves as Associate Dean for Clinical Affairs, Community Engagement and Population Health for CHSU’s College of Osteopathic Medicine. Prior to her appointment at CHSU, she served as the Assistant Dean of Clinical Affairs and Vice Chair of Primary Care at Kansas City University of Medicine, where she was also an Assistant Professor of Pediatrics. At KCU, Dr. VanGarsse oversaw the clinical faculty in the department of Primary Care, as well as the university practice plan and university relationships with community partners. As part of her role at KCU, she additionally served as the Chief Health Officer for Health Partnership Clinic, a Federally Qualified Health Center in Olathe, Kansas. Through her work at KCU and HPC, she strove to combine medical student education into safety net medicine, to instill a passion for safety net medicine in future physicians.
A board certified pediatrician by training, Dr VanGarsse received her BS in Biology from Rockhurst University and her MD from St Louis University, where she also completed her pediatric residency. Upon residency completion, Dr VanGarsse practiced in the private sector for 11 years, before returning to her native Kansas City to pursue and academic career with KCU. Dr VanGarsse recently obtained the prestigious Certified Physician Executive (CPE) designation. She is also a graduate of University of Kansas Medical Center Community Health Center Executive Fellowship.
Dr VanGarsse has a passion for incorporating all the tenets of health system science into medical student education, with an overall goal of improving the health outcomes of underserved patients.
Dr VanGarsse additionally serves as a member of the American Medical Association, the American Academy of Pediatrics, is a diplomate of the American Board of Pediatrics, for which she served as a member of the standard setting panel in 2017, and a member of the American Association for Physician Leadership, as well as other academic and pediatric organizations.
Associate Professor of Social and Economic Sciences 559-546-6024 swan@chsu.edu
Anna Yang, MLIS, AHIP
Health Sciences Librarian Instructor of Social and Economic Sciences 559-573-8123 ayang@chsu.edu
College of Osteopathic Medicine
Office of the DeanAcademic AffairsBiomedical Education DepartmentClinical Affairs & Community EngagementFinancial AidGraduate Medical EducationOsteopathic Clinical EducationRegistrarSimulation CenterStudent Affairs and Admissions
John Graneto, DO, MEd, FACOP, FACOEP-dist, FNAOME serves as the Dean of our College of Osteopathic Medicine at California Health Sciences University (CHSU).
Prior to joining CHSU, Dr. Graneto served as Associate Dean and Professor of Pediatrics and Emergency Medicine at the Kansas City University College of Osteopathic Medicine. His past service also includes, serving as Founding Chair of the Department of Clinical Integration and Pediatric Residency Program Director in the College of Osteopathic Medicine at Midwestern University Chicago College of Osteopathic Medicine.
He received his Doctor of Osteopathic Medicine at Ohio University in Athens, Ohio and his Master of Education (Health) at the University of Cincinnati. He completed his Pediatric Residency and Emergency Medicine Residency at Midwestern University Chicago College of Osteopathic Medicine.
Associate Dean for Academic Affairs Professor 559-712-4200 mqureshi@chsu.edu
Mahboob Qureshi, MD, MPH, PhD, serves as the Associate Dean for Academic Affairs. He joins the California Health Sciences University (CHSU) College of Osteopathic Medicine (COM) with very robust experiences in medical education and academic medicine. He has extensive educational background in clinical and biomedical sciences as well as in the fields of public health. He joins the leadership team to accomplish the missions of the COM by developing and implementing a modern, effective, student-centered and active-learning based curriculum, which will enable our graduates to become highly competent and caring physicians practicing evidence-based medicine.
Dr. Qureshi has many experiences in developing a new medical school as a founding faculty member at the Touro University Nevada (TUN) COM, where he made significant contributions over a span of almost 15 years as a Professor and an Associate Dean for its successful growth and achievements.
Dr. Qureshi loves academic medicine and medical education as he can be in direct contact with the aspiring physicians and can be a part of their “dream-come-true” experiences. Through his academic career, Dr. Qureshi received Professor of the Year awards (10 times) for his teaching excellence, and was widely recognized by his students as a major resource when taking the Medical Boards (e. g. COMLEX and USMLE) exams, reflecting his passion for student learning and touching many lives. Dr. Qureshi is a senior faculty at the KAPLAN Medical which offers preparatory courses for the medical licensing exams (COMLEX and USMLE) to the aspiring physicians throughout the United States. Working in collaboration with the biomedical sciences and clinical faculty members and other COM leadership, Dr. Qureshi will serve the CHSU-COM students to become the finest physician in their community and their professional arena.
Chair of Biomedical Education Professor 559-712-4200 cburns@chsu.edu
As department chair, Dr. Burns seeks to create a productive and collegial environment within the department, and across the university. His goal is to develop a cadre of faculty who embrace and role-model collaboration and teamwork, which are the core of CHSU education programs.
Dr. Burns earned his B.Sc. in Microbiology and Immunology from McGill University in Montreal, Canada and his Ph.D. in Molecular, Cellular, and Development Biology from Indiana University in Bloomington. He completed post-doctoral training in clinical biochemistry and microbial genetics at the University of Oxford and Imperial Cancer Research Fund in the United Kingdom. As principal investigator, he conducted NSF and NIH-funded biomedical science research in his laboratory before he transitioned to concentrate on medical education.
Dr. Burns is a leader developing new medical schools and implementing innovative education programs. He has focused on preparing students for enduring professional careers by promoting life-long learning habits and linking underlying biomedical science knowledge to clinical skills. He brings to CHSU expertise in faculty development for collaborative learning across medical and health science school preclinical curricula, particularly team-based learning (TBL) and problem-based learning (PBL).
He serves the broader education community as Treasurer and Trainer-Consultant for the Team-Based Learning Collaborative, Chair of the International Association of Medical Science Educators (IAMSE) Student Professional Development Committee, and mentor for faculty in leadership and education certificate programs.
Dr. Burns is also a healthcare provider, delivering pre-hospital emergency care at special events, conferences, and festivals as an Advanced-EMT with the Guardian Elite Medical Services of Las Vegas, NV.
Associate Dean for Clinical Affairs, Community Engagement and Population Health Associate Professor 559-712-4200 avangarsse@chsu.edu
Dr Anne VanGarsse serves as Associate Dean for Clinical Affairs, Community Engagement and Population Health for CHSU’s College of Osteopathic Medicine. Prior to her appointment at CHSU, she served as the Assistant Dean of Clinical Affairs and Vice Chair of Primary Care at Kansas City University of Medicine, where she was also an Assistant Professor of Pediatrics. At KCU, Dr. VanGarsse oversaw the clinical faculty in the department of Primary Care, as well as the university practice plan and university relationships with community partners. As part of her role at KCU, she additionally served as the Chief Health Officer for Health Partnership Clinic, a Federally Qualified Health Center in Olathe, Kansas. Through her work at KCU and HPC, she strove to combine medical student education into safety net medicine, to instill a passion for safety net medicine in future physicians.
A board certified pediatrician by training, Dr VanGarsse received her BS in Biology from Rockhurst University and her MD from St Louis University, where she also completed her pediatric residency. Upon residency completion, Dr VanGarsse practiced in the private sector for 11 years, before returning to her native Kansas City to pursue and academic career with KCU. Dr VanGarsse recently obtained the prestigious Certified Physician Executive (CPE) designation. She is also a graduate of University of Kansas Medical Center Community Health Center Executive Fellowship.
Dr VanGarsse has a passion for incorporating all the tenets of health system science into medical student education, with an overall goal of improving the health outcomes of underserved patients.
Dr VanGarsse additionally serves as a member of the American Medical Association, the American Academy of Pediatrics, is a diplomate of the American Board of Pediatrics, for which she served as a member of the standard setting panel in 2017, and a member of the American Association for Physician Leadership, as well as other academic and pediatric organizations.
Associate Dean of Graduate Medical Education Assistant Professor 559-712-4200 rculbertson@chsu.edu
Dr. Culbertson most recently served as the Chief Development Officer of Tenet Health (Desert Regional Medical Center-Palm Springs) in the Coachella Valley. In this position, he supervised all activities around growth, service line planning, physician relations activities, marketing, business planning, and strategic planning for the Coachella Valley including collaboration between the two Tenet facilities. In addition he was the Vice-President of Graduate Medical Education and the Director of Medical Education and Designated Institutional Official starting five residency programs in 20015-16.
A board-certified family practitioner by training, Dr. Culbertson earned his Doctor of Osteopathic Medicine degree from Kansas City University of Medicine and Biosciences, and his Bachelor of Science degree in Chemistry from Missouri State University. Dr. Culbertson has excelled in various roles throughout his career in health care including, practicing family medicine for over 15 years and serving as the Chief of Family Medicine at St. Mary’s Hospital of Blue Springs and being elected as Chief of Staff at St. Mary’s as well. He then became the Chief Medical Officer for the Carondelet Health System which later became part of Ascension Health for seven years. He then served as a physician consultant for Cerner designing, implementing, training, and guiding acceptance of electronic medical records around the country. He then took a role with HCA Midwest as the VP for business development for eastern Kansas City for five years before moving to California.
Dr. Culbertson has a passion for building relationships with physicians based on mutual trust, understanding their interests and concerns, and resolving any issues that may come up as quickly as possible while maintaining a great relationship. This skill set will be well suited in his new role at CHSU as he builds relationships with physicians in our community to secure clerkships and residency sites for the CHSU College of Osteopathic Medicine.
Additionally, Dr. Culbertson is a member of the American Osteopathic Association, the Missouri Association of Osteopathic Physician and Surgeons. the American Association of Osteopathic Family Physicians, and the American Association of Osteopathic Directors of Medical Education as well as other national organizations.
Associate Dean for Osteopathic Clinical Education Associate Professor 559-712-4200 lchun@chsu.edu
Dr. Lisa Chun is excited to join a fabulous team in the development of the new osteopathic medical school that will change the Central Valley region of California. Dr. Chun has a passion for integrating osteopathic principles and practices throughout the continuum of osteopathic medical education.
Dr. Chun serves as the Associate Dean for Osteopathic Clinical Education. She is a graduate of the New York College of Osteopathic Medicine and is specialty board certified in Neuromusculoskeletal Medicine/Osteopathic Manipulative Medicine. She was a Pre-Doctoral Osteopathic Principles and Practices Teaching Fellow and the chief resident for the inaugural Neuromusculoskeletal Medicine Residency at St. Barnabas Hospital in the Bronx. Dr. Chun was in private practice for 16 years before entering academia full time. She obtained her Master of Science in Medical Education Leadership through the University of New England.
Over the last several years, Dr. Chun has had the opportunity to work at a number of different developing colleges of osteopathic medicine around the country. She has taught extensively and has held positions that included course director, founding Osteopathic Principles and Practices Pre-doctoral Fellowship Director, Osteopathic Manipulative Medicine Department Chair, and founding Neuromusculoskeletal Medicine Plus-One Residency Director.
She serves nationally on committees of the National Board of Osteopathic Medical Examiners, American Academy of Osteopathy, and American Association of Colleges of Osteopathic Medicine.
Chair, Specialty Medicine Associate Professor 559-712-4200 kbedi@chsu.edu
Originally from Southern California, Kristopher Bedi, DO, FACOG, is a board certified OB/Gyn from the American Board of Obstetrics and Gynecology and serves as the Chair of the Department of Specialty Medicine for the College of Osteopathic Medicine.
He graduated from Midwestern University, Chicago College of Osteopathic Medicine and completed his residency in Obstetrics and Gynecology at the Stamford Hospital – Columbia University College of Physicians and Surgeons. He then went on and completed a Fellowship in Minimally Invasive Gynecologic Surgery at the Women’s Health Institute of Illinois in Chicago, Illinois.
Dr. Bedi has had many leadership positions during his medical career. He most recently served as the Director of Obstetrics of Gynecology at Van Diest Medical Center. Throughout his career he has been an active member in many organizations, including the American College of Obstetricians and Gynecologists, the American Association of Gynecologic Laparoscopists and the American Osteopathic Association. He has served as a delegate from Illinois to the AOA Congress and as a state delegate in Iowa.
Dr. Bedi’s special interests lie in Medical Education and Minimally Invasive Surgery. He began his teaching career during his fellowship and has continually taught medical students and residents. He has held academic teaching positions at Midwestern University, Des Moines University and the University of Illinois, Chicago prior to his arrival at California Health Sciences University.
Leslie Catron, M.A.ED, BSN, RN, CHSE, serves as the Manager of the California Health Sciences University College of Osteopathic Medicine Simulation Center. Participating in the development of this new fully functional center with standardized patients, virtual and high fidelity simulation, Leslie is also involved in training new faculty in simulation and developing curriculum for the college of pharmacology and college of osteopathic medicine. Leaving her position as Clinical Education Specialist Simulation Coordinator at Valley Children’s Healthcare, she developed and implemented a sustainable interprofessional simulation program with physicians and clinical educators in all departments of the organization, including disaster training.
Leslie started in the NICU in 1975 as a new graduate registered nurse (RN). While in the NICU, she not only took care of complex premature infants and was a transport team member, but she oversaw the new employee orientation and RN student extern program.
She became a clinical educator, moving to central education and developed an interactive hospital orientation program, revised and taught the interprofessional preceptor program and coordinated the organizational RN student extern program.
She obtained her M.A.ED, curriculum and teaching degree in 2009 and Certificate in Simulation Education in 2012 from BryanLGH College of Health Sciences. From 2008-14, she was the faculty Simulation Coordinator at West Hills College Lemoore, where she developed an ADN and allied health careers simulation program and taught pediatrics in the nursing program.
In 2013 and 2016, she obtained her Certified Healthcare Simulation Educator with SSIH. In 2013 and 2018, she was a contributing author to “Simulation Scenarios for Nursing Educators: Making It Real” Editions 2 and 3. She is an Editorial Board Member and manuscript reviewer for the Clinical Simulation in Nursing Journal through the International Nursing Association for Clinical Simulation and Learning (INASCL). She is faculty for the California Simulation Alliance, a program of HealthImpact and founding co-chair for the Central Valley Simulation Collaborative. She serves on the INACSL Organization Liaison Committee.
Leslie has presented multiple workshops, podiums posters, and webinars at the Society for Simulation in Healthcare (SSIH), the International Nursing Association for Clinical Simulation and Leaning (INASCL) ,the International Pediatric Simulation Society (IPSS), along with other state and local area conferences.
